1
|
Becker TK, Lykens D, Jones JM, Justice BT, Carr CT. Small ventilation bags and cardiac arrest outcomes - Not so fast. Resuscitation 2024; 194:110083. [PMID: 38220419 DOI: 10.1016/j.resuscitation.2023.110083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Accepted: 11/25/2023] [Indexed: 01/16/2024]
Affiliation(s)
- Torben K Becker
- Division of Emergency Medical Services, Department of Emergency Medicine, College of Medicine, University of Florida, Gainesville, FL, USA; Division of Critical Care Medicine, Department of Emergency Medicine, College of Medicine, University of Florida, Gainesville, FL, USA; Alachua County Fire Rescue, Gainesville, FL, USA.
| | - David Lykens
- Alachua County Fire Rescue, Gainesville, FL, USA
| | - Jason M Jones
- Division of Emergency Medical Services, Department of Emergency Medicine, College of Medicine, University of Florida, Gainesville, FL, USA; Alachua County Fire Rescue, Gainesville, FL, USA
| | | | - Casey T Carr
- Division of Critical Care Medicine, Department of Emergency Medicine, College of Medicine, University of Florida, Gainesville, FL, USA
| |
Collapse
|
2
|
Litton JK, Beck JT, Jones JM, Andersen J, Blum JL, Mina LA, Brig R, Danso M, Yuan Y, Abbattista A, Noonan K, Niyazov A, Chakrabarti J, Czibere A, Symmans WF, Telli ML. Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study. Oncologist 2023; 28:845-855. [PMID: 37318349 PMCID: PMC10546823 DOI: 10.1093/oncolo/oyad139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Accepted: 04/14/2023] [Indexed: 06/16/2023] Open
Abstract
BACKGROUND The undetermined efficacy of the current standard-of-care neoadjuvant treatment, anthracycline/platinum-based chemotherapy, in patients with early-stage triple-negative breast cancer (TNBC) and germline BRCA mutations emphasizes the need for biomarker-targeted treatment, such as poly(ADP-ribose) polymerase inhibitors, in this setting. This phase II, single-arm, open-label study evaluated the efficacy and safety of neoadjuvant talazoparib in patients with germline BRCA1/2-mutated early-stage TNBC. PATIENTS AND METHODS Patients with germline BRCA1/2-mutated early-stage TNBC received talazoparib 1 mg once daily for 24 weeks (0.75 mg for moderate renal impairment) followed by surgery. The primary endpoint was pathologic complete response (pCR) by independent central review (ICR). Secondary endpoints included residual cancer burden (RCB) by ICR. Safety and tolerability of talazoparib and patient-reported outcomes were assessed. RESULTS Of 61 patients, 48 received ≥80% talazoparib doses, underwent surgery, and were assessed for pCR or progressed before pCR assessment and considered nonresponders. pCR rate was 45.8% (95% confidence interval [CI], 32.0%-60.6%) and 49.2% (95% CI, 36.7%-61.6%) in the evaluable and intent-to-treat (ITT) population, respectively. RCB 0/I rate was 45.8% (95% CI, 29.4%-63.2%) and 50.8% (95% CI, 35.5%-66.0%) in the evaluable and ITT population, respectively. Treatment-related adverse events (TRAE) were reported in 58 (95.1%) patients. Most common grade 3 and 4 TRAEs were anemia (39.3%) and neutropenia (9.8%). There was no clinically meaningful detriment in quality of life. No deaths occurred during the reporting period; 2 deaths due to progressive disease occurred during long-term follow-up (>400 days after first dose). CONCLUSIONS Neoadjuvant talazoparib monotherapy was active despite pCR rates not meeting the prespecified threshold; these rates were comparable to those observed with combination anthracycline- and taxane-based chemotherapy regimens. Talazoparib was generally well tolerated. CLINICALTRIALS.GOV IDENTIFIER NCT03499353.
Collapse
Affiliation(s)
- Jennifer K Litton
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - J Thaddeus Beck
- Department of Medical Oncology and Hematology, Highlands Oncology, Springdale, AR, USA
| | - Jason M Jones
- Avera Medical Group Oncology & Hematology, Avera Cancer Institute, Sioux Falls, SD, USA
| | - Jay Andersen
- Medical Oncology, Compass Oncology, West Cancer Center, US Oncology Network, Tigard, OR, USA
| | - Joanne L Blum
- Department of Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, TX, USA
| | - Lida A Mina
- Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA
| | - Raymond Brig
- Medical Oncology, Brig Center for Cancer Care and Survivorship, Knoxville, TN, USA
| | - Michael Danso
- Medical Oncology, Virginia Oncology Associates, Norfolk, VA, USA
| | - Yuan Yuan
- Department of Medical Oncology & Therapeutics Research, Cedars-Sinai Cancer Center, West Hollywood, CA, USA
| | | | - Kay Noonan
- Clinical Oncology, Pfizer Inc., Groton, CT, USA
| | | | | | - Akos Czibere
- Oncology Drug Development, Pfizer Inc., Cambridge, MA, USA
| | - William F Symmans
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Melinda L Telli
- Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
| |
Collapse
|
3
|
Anderson EK, Baker CJ, Bertsche W, Bhatt NM, Bonomi G, Capra A, Carli I, Cesar CL, Charlton M, Christensen A, Collister R, Cridland Mathad A, Duque Quiceno D, Eriksson S, Evans A, Evetts N, Fabbri S, Fajans J, Ferwerda A, Friesen T, Fujiwara MC, Gill DR, Golino LM, Gomes Gonçalves MB, Grandemange P, Granum P, Hangst JS, Hayden ME, Hodgkinson D, Hunter ED, Isaac CA, Jimenez AJU, Johnson MA, Jones JM, Jones SA, Jonsell S, Khramov A, Madsen N, Martin L, Massacret N, Maxwell D, McKenna JTK, Menary S, Momose T, Mostamand M, Mullan PS, Nauta J, Olchanski K, Oliveira AN, Peszka J, Powell A, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Schoonwater J, Silveira DM, Singh J, Smith G, So C, Stracka S, Stutter G, Tharp TD, Thompson KA, Thompson RI, Thorpe-Woods E, Torkzaban C, Urioni M, Woosaree P, Wurtele JS. Observation of the effect of gravity on the motion of antimatter. Nature 2023; 621:716-722. [PMID: 37758891 PMCID: PMC10533407 DOI: 10.1038/s41586-023-06527-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2023] [Accepted: 08/09/2023] [Indexed: 09/29/2023]
Abstract
Einstein's general theory of relativity from 19151 remains the most successful description of gravitation. From the 1919 solar eclipse2 to the observation of gravitational waves3, the theory has passed many crucial experimental tests. However, the evolving concepts of dark matter and dark energy illustrate that there is much to be learned about the gravitating content of the universe. Singularities in the general theory of relativity and the lack of a quantum theory of gravity suggest that our picture is incomplete. It is thus prudent to explore gravity in exotic physical systems. Antimatter was unknown to Einstein in 1915. Dirac's theory4 appeared in 1928; the positron was observed5 in 1932. There has since been much speculation about gravity and antimatter. The theoretical consensus is that any laboratory mass must be attracted6 by the Earth, although some authors have considered the cosmological consequences if antimatter should be repelled by matter7-10. In the general theory of relativity, the weak equivalence principle (WEP) requires that all masses react identically to gravity, independent of their internal structure. Here we show that antihydrogen atoms, released from magnetic confinement in the ALPHA-g apparatus, behave in a way consistent with gravitational attraction to the Earth. Repulsive 'antigravity' is ruled out in this case. This experiment paves the way for precision studies of the magnitude of the gravitational acceleration between anti-atoms and the Earth to test the WEP.
Collapse
Affiliation(s)
- E K Anderson
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - C J Baker
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - W Bertsche
- School of Physics and Astronomy, University of Manchester, Manchester, UK.
- Cockcroft Institute, Sci-Tech Daresbury, Warrington, UK.
| | - N M Bhatt
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - G Bonomi
- University of Brescia, Brescia and INFN Pavia, Pavia, Italy
| | - A Capra
- TRIUMF, Vancouver, British Columbia, Canada
| | - I Carli
- TRIUMF, Vancouver, British Columbia, Canada
| | - C L Cesar
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - M Charlton
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - A Christensen
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - R Collister
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - A Cridland Mathad
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - D Duque Quiceno
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - S Eriksson
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - A Evans
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - N Evetts
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - S Fabbri
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Accelerator and Technology Sector, CERN, Geneva, Switzerland
| | - J Fajans
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA.
| | - A Ferwerda
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - T Friesen
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | | | - D R Gill
- TRIUMF, Vancouver, British Columbia, Canada
| | - L M Golino
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - M B Gomes Gonçalves
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | | | - P Granum
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - J S Hangst
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark.
| | - M E Hayden
- Department of Physics, Simon Fraser University, Burnaby, British Columbia, Canada
| | - D Hodgkinson
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - E D Hunter
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - C A Isaac
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | | | - M A Johnson
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Cockcroft Institute, Sci-Tech Daresbury, Warrington, UK
| | - J M Jones
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - S A Jones
- Van Swinderen Institute for Particle Physics and Gravity, University of Groningen, Groningen, The Netherlands
| | - S Jonsell
- Department of Physics, Stockholm University, Stockholm, Sweden
| | - A Khramov
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
- Department of Physics, British Columbia Institute of Technology, Burnaby, British Columbia, Canada
| | - N Madsen
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - L Martin
- TRIUMF, Vancouver, British Columbia, Canada
| | | | - D Maxwell
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - J T K McKenna
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
- School of Physics and Astronomy, University of Manchester, Manchester, UK
| | - S Menary
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - T Momose
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
- Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada
| | - M Mostamand
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada
| | - P S Mullan
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
- Institute for Particle Physics and Astrophysics, ETH, Zurich, Switzerland
| | - J Nauta
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | | | - A N Oliveira
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - J Peszka
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
- Institute for Particle Physics and Astrophysics, ETH, Zurich, Switzerland
| | - A Powell
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - C Ø Rasmussen
- Experimental Physics Department, CERN, Geneva, Switzerland
| | - F Robicheaux
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN, USA
| | - R L Sacramento
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - M Sameed
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Accelerator Systems Department, CERN, Geneva, Switzerland
| | - E Sarid
- Soreq NRC, Yavne, Israel
- Department of Physics, Ben Gurion University, Beer Sheva, Israel
| | - J Schoonwater
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - D M Silveira
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - J Singh
- School of Physics and Astronomy, University of Manchester, Manchester, UK
| | - G Smith
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - C So
- TRIUMF, Vancouver, British Columbia, Canada
| | | | - G Stutter
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
- School of Mathematical and Physical Sciences, University of Sussex, Brighton, UK
| | - T D Tharp
- Physics Department, Marquette University, Milwaukee, WI, USA
| | - K A Thompson
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - R I Thompson
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - E Thorpe-Woods
- Department of Physics, Faculty of Science and Engineering, Swansea University, Swansea, UK
| | - C Torkzaban
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - M Urioni
- University of Brescia, Brescia and INFN Pavia, Pavia, Italy
| | - P Woosaree
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - J S Wurtele
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| |
Collapse
|
4
|
Ma CX, Luo J, Freedman RA, Pluard TJ, Nangia JR, Lu J, Valdez-Albini F, Cobleigh M, Jones JM, Lin NU, Winer EP, Marcom PK, Anderson J, Thomas S, Haas B, Bucheit L, Bryce R, Lalani AS, Carey LA, Goetz MP, Gao F, Kimmick G, Pegram MD, Ellis MJ, Bose R. The phase II MutHER study of neratinib alone and in combination with fulvestrant in HER2 mutated, non-amplified metastatic breast cancer. Clin Cancer Res 2022; 28:1258-1267. [PMID: 35046057 DOI: 10.1158/1078-0432.ccr-21-3418] [Citation(s) in RCA: 25] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Revised: 12/01/2021] [Accepted: 01/13/2022] [Indexed: 11/16/2022]
Abstract
PURPOSE HER2 mutations (HER2mut) induce endocrine resistance in estrogen receptor positive (ER+) breast cancer. EXPERIMENTAL DESIGN In this single arm multi-cohort phase II trial, we evaluated the efficacy of neratinib plus fulvestrant in patients with ER+/HER2mut, HER2-non-amplified metastatic breast cancer (MBC) in the fulvestrant-treated (n=24) or fulvestrant-naïve cohort (n=11). Patients with ER-negative/HER2mut MBC received neratinib monotherapy in an exploratory ER- cohort (n=5). RESULTS The clinical benefit rate (CBR: 95% CI) was 38% (18-62%), 30% (7-65%), and 25% (1-81%) in the fulvestrant-treated, fulvestrant-naïve, and ER- cohort, respectively. Adding trastuzumab at progression in 5 patients resulted in 3 partial responses and 1 stable disease {greater than or equal to}24 weeks. CBR appeared positively associated with lobular histology and negatively associated with HER2 L755 alterations. Acquired HER2mut were detected in 5 of 23 patients at progression. CONCLUSION Neratinib and fulvestrant is active for ER+/HER2mut MBC. Our data supports further evaluation of dual HER2 blockade for the treatment of HER2mut MBC.
Collapse
Affiliation(s)
- Cynthia X Ma
- Division of Oncology, Department of Internal Medicine, Washington University in St. Louis School of Medicine
| | - Jingqin Luo
- Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine
| | | | | | | | - Janice Lu
- Medicine, University of Southern California
| | | | - Melody Cobleigh
- Rush University Cancer Center, Rush University Medical Center
| | | | - Nancy U Lin
- Medical Oncology, Dana-Farber Cancer Institute
| | - Eric P Winer
- Division of Breast Oncology, Dana-Farber Cancer Institute
| | | | | | - Shana Thomas
- Internal Medicine, Washington University in St. Louis School of Medicine
| | - Brittney Haas
- Division of Oncology, Department of Medicine, Washington University in St. Louis School of Medicine
| | | | | | | | - Lisa A Carey
- Medicine, University of North Carolina School of Medicine
| | | | - Feng Gao
- Department of Surgery, Washington University in St. Louis School of Medicine
| | - Gretchen Kimmick
- Department of Medicine, Division of Medical Oncology, Duke Medical Center
| | - Mark D Pegram
- Department of Medicine, Stanford Comprehensive Cancer Institute
| | - Matthew J Ellis
- Lester and Sue Smith Breast Center, Baylor College of Medicine
| | - Ron Bose
- Medicine, Division of Oncology, Washington University in St. Louis School of Medicine
| |
Collapse
|
5
|
Grünwald CI, Toribio-Jiménez S, Montaño-Ruvalcaba C, Franz-Chávez H, Peñaloza-Montaño MA, Barrera-Nava EY, Jones JM, Rodriguez CM, Hughes IM, Strickland JL, Reyes-Velasco J. Two new species of snail-eating snakes of the genus Tropidodipsas (Serpentes, Dipsadidae) from southern Mexico, with notes on related species. HERPETOZOA 2021. [DOI: 10.3897/herpetozoa.34.e69176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
We describe two new species of Tropidodipsas related to the T. fasciata species group as defined by Kofron (1987), and provide morphological and molecular data to support the novelty of both species. A partial molecular phylogeny of the Mexican species of snail-eating snakes (Serpentes, Dipsadidae) is presented, and we discuss evolutionary relationships as supported by our molecular results. We analyze specific relationships of the new species described herein with their closest relatives. We present a distribution map for all species of Tropidodipsas and include photographs of living individuals of each species. Finally, we discuss other taxonomic changes based on our molecular phylogeny as well as conservation priorities of the new species.
Collapse
|
6
|
Baker CJ, Bertsche W, Capra A, Cesar CL, Charlton M, Mathad AC, Eriksson S, Evans A, Evetts N, Fabbri S, Fajans J, Friesen T, Fujiwara MC, Grandemange P, Granum P, Hangst JS, Hayden ME, Hodgkinson D, Isaac CA, Johnson MA, Jones JM, Jones SA, Jonsell S, Kurchaninov L, Madsen N, Maxwell D, McKenna JTK, Menary S, Momose T, Mullan P, Olchanski K, Olin A, Peszka J, Powell A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, Stutter G, So C, Tharp TD, Thompson RI, van der Werf DP, Wurtele JS. Sympathetic cooling of positrons to cryogenic temperatures for antihydrogen production. Nat Commun 2021; 12:6139. [PMID: 34686658 PMCID: PMC8536749 DOI: 10.1038/s41467-021-26086-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Accepted: 09/13/2021] [Indexed: 11/25/2022] Open
Abstract
The positron, the antiparticle of the electron, predicted by Dirac in 1931 and discovered by Anderson in 1933, plays a key role in many scientific and everyday endeavours. Notably, the positron is a constituent of antihydrogen, the only long-lived neutral antimatter bound state that can currently be synthesized at low energy, presenting a prominent system for testing fundamental symmetries with high precision. Here, we report on the use of laser cooled Be+ ions to sympathetically cool a large and dense plasma of positrons to directly measured temperatures below 7 K in a Penning trap for antihydrogen synthesis. This will likely herald a significant increase in the amount of antihydrogen available for experimentation, thus facilitating further improvements in studies of fundamental symmetries.
Collapse
Affiliation(s)
- C J Baker
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK
| | - W Bertsche
- School of Physics and Astronomy, University of Manchester, Manchester, M12 9PL, UK
- Cockcroft Institute, Sci-Tech Daresbury, Warrington, WA4 4AD, UK
| | - A Capra
- TRIUMF, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada
| | - C L Cesar
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 21941-972, Brazil
| | - M Charlton
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK
| | - A Cridland Mathad
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK
| | - S Eriksson
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK
| | - A Evans
- Department of Physics and Astronomy, University of Calgary, Calgary, AB, T2N 1N4, Canada
| | - N Evetts
- Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, V6T 1Z1, Canada
| | - S Fabbri
- School of Physics and Astronomy, University of Manchester, Manchester, M12 9PL, UK
| | - J Fajans
- Department of Physics, University of California at Berkeley, Berkeley, CA, 94720-7300, USA
| | - T Friesen
- Department of Physics and Astronomy, University of Calgary, Calgary, AB, T2N 1N4, Canada
| | - M C Fujiwara
- TRIUMF, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada
| | - P Grandemange
- TRIUMF, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada
| | - P Granum
- Department of Physics and Astronomy, Aarhus University, DK-8000, Aarhus C, Denmark
| | - J S Hangst
- Department of Physics and Astronomy, Aarhus University, DK-8000, Aarhus C, Denmark
| | - M E Hayden
- Department of Physics, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada
| | - D Hodgkinson
- School of Physics and Astronomy, University of Manchester, Manchester, M12 9PL, UK
| | - C A Isaac
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK
| | - M A Johnson
- School of Physics and Astronomy, University of Manchester, Manchester, M12 9PL, UK
| | - J M Jones
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK
| | - S A Jones
- Department of Physics and Astronomy, Aarhus University, DK-8000, Aarhus C, Denmark
| | - S Jonsell
- Department of Physics, Stockholm University, SE-10691, Stockholm, Sweden
| | - L Kurchaninov
- TRIUMF, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada
| | - N Madsen
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK.
| | - D Maxwell
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK.
| | - J T K McKenna
- Department of Physics and Astronomy, Aarhus University, DK-8000, Aarhus C, Denmark
| | - S Menary
- Department of Physics and Astronomy, York University, Toronto, ON, M3J 1P3, Canada
| | - T Momose
- Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, V6T 1Z1, Canada
| | - P Mullan
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK
| | - K Olchanski
- TRIUMF, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada
| | - A Olin
- TRIUMF, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada
| | - J Peszka
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK
| | - A Powell
- Department of Physics and Astronomy, University of Calgary, Calgary, AB, T2N 1N4, Canada
| | - P Pusa
- Department of Physics, University of Liverpool, Liverpool, L69 7ZE, UK
| | - C Ø Rasmussen
- Experimental Physics Department, CERN, Geneva, 1211, Switzerland
| | - F Robicheaux
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN, 47907, USA
| | - R L Sacramento
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 21941-972, Brazil
| | - M Sameed
- School of Physics and Astronomy, University of Manchester, Manchester, M12 9PL, UK
| | - E Sarid
- Soreq NRC, 81800, Yavne, Israel
- Department of Physics, Ben Gurion University, 8410501, Beer Sheva, Israel
| | - D M Silveira
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 21941-972, Brazil
| | - G Stutter
- Department of Physics and Astronomy, Aarhus University, DK-8000, Aarhus C, Denmark
| | - C So
- Department of Physics and Astronomy, University of Calgary, Calgary, AB, T2N 1N4, Canada
| | - T D Tharp
- Physics Department, Marquette University, P.O. Box 1881, Milwaukee, WI, 53201-1881, USA
| | - R I Thompson
- Department of Physics and Astronomy, University of Calgary, Calgary, AB, T2N 1N4, Canada
| | - D P van der Werf
- Department of Physics, College of Science, Swansea University, Swansea, SA2 8PP, UK
| | - J S Wurtele
- Department of Physics, University of California at Berkeley, Berkeley, CA, 94720-7300, USA
| |
Collapse
|
7
|
Jones JM, Hu YD, Eid MA, Sensenig CJ, Mehta KS, Goldwag JL, Barnes JA, Kang R, Barry MJ, Spangler EL, Nelson PR, Mureebe L, Tang G, Tzeng E, Alabi O, Halpern VJ, Stone DH, Brooke BS, Moore K, Henke P, Scali S, O'Connell J, Goodney PP. Short-Term Concerns Primarily Determine Patient Preference for Abdominal Aortic Aneurysm Repair. J Surg Res 2021; 269:119-128. [PMID: 34551368 DOI: 10.1016/j.jss.2021.07.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2021] [Revised: 06/26/2021] [Accepted: 07/22/2021] [Indexed: 10/20/2022]
Abstract
INTRODUCTION Abdominal aortic aneurysm (AAA) repair may be performed through open or endovascular approaches, but the factors influencing a patient's repair-type preference are not well characterized. Here we performed a qualitative analysis to better understand factors influencing patient preference within the Preference for Open Versus Endovascular Repair of AAA Trial. METHODS Open-ended responses regarding primary (n = 21) and secondary (n = 47) factors influencing patient preference underwent qualitative analysis using the constant comparative method with iterative reviews. Codes were used to generate themes and themes grouped into categories, with each step conducted via consensus agreement between three researchers. Relative prevalence of themes were compared to ascertain trends in patient preference. RESULTS Patient responses regarding both primary and secondary factors fell into four categories: Short-term concerns, long-term concerns, advice & experience, and other. Patients most frequently described short-term concerns (23) as their primary influence, with themes including post-op complications, hospitalization & recovery, and intraoperative concerns. Long-term concerns were more prevalent (20) as secondary factors, which included themes such as survival, and chronic management. The average age of patients voicing only long-term concerns as a primary factor was 11 years younger than those listing only short-term concerns. CONCLUSION Short-term concerns relating to the procedure and recovery are more often the primary factor influencing patient preference, while long term concerns play a more secondary role. Long-term concerns are more often a primary factor in younger patients. Vascular surgeons should consider this information in shared decision making to reach an optimal outcome.
Collapse
Affiliation(s)
- J M Jones
- The Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire
| | - Y D Hu
- The Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire
| | - M A Eid
- Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vermont
| | | | - K S Mehta
- Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vermont
| | - J L Goldwag
- Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vermont
| | - J A Barnes
- Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vermont
| | - R Kang
- Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
| | - M J Barry
- Massachusetts General Hospital Center for Shared Decision Making, Boston, Massachusetts
| | | | - P R Nelson
- Muskogee VAMC, Muskogee, Okla; Tampa VAMC, Tampa Bay, Florida
| | | | - G Tang
- Seattle VAMC, Seattle, Washington
| | - E Tzeng
- Pittsburgh VAMC, Pittsburgh, Pennsylvania
| | - O Alabi
- Atlanta VAMC, Atlanta, Georgia
| | | | - D H Stone
- Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
| | | | - K Moore
- The Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire
| | - P Henke
- Ann Arbor VAMC, Ann Arbor, Michigan
| | - S Scali
- Gainesville VAMC, Gainesville, Florida
| | | | - P P Goodney
- Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vermont.
| |
Collapse
|
8
|
Freeman KE, Winston-Proctor CE, Gangloff-Bailey F, Jones JM. Racial Identity-Rooted Academic Motivation of First-Year African American Students Majoring in STEM at an HBCU. Front Psychol 2021; 12:669407. [PMID: 34168596 PMCID: PMC8217429 DOI: 10.3389/fpsyg.2021.669407] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Accepted: 05/03/2021] [Indexed: 11/24/2022] Open
Abstract
The purpose the present study is to explore African American undergraduate students' perceptions of their experiences and academic motivation within a Historically Black College or University (HBCU) learning environment. As part of a larger study, we collected 212 open-ended survey responses from first year students in STEM majors about how the HBCU context shapes their academic motivation. We used semantic thematic data analysis and found three major themes and corresponding sub themes that were salient in the development of students' academic motivation: place (institutional climate, HBCU mission and tradition, and absence of marginalization); pedagogy (culturally relevant pedagogy, positive faculty-student relationships, African American curriculum and instruction, racial socialization); and people (people “like me”; student, faculty and alumni models of high achieving African Americans). We discovered that HBCU institutional factors engendered academic motivation that is rooted in students' racial identity and suggest the construct of racial identity-rooted academic motivation. Given the important and unique realities of African American students that impact their educational experiences, engagement, identity development, and achievement in various types of school contexts, self and sociocultural variables must be included in research and theory on the motivational psychology of African American students. Implications for higher education practice and future research are discussed.
Collapse
Affiliation(s)
- Kimberley Edelin Freeman
- Department of Human Development & Psychoeducational Studies, Howard University, Washington, DC, United States.,School of Education, Graduate School of Arts & Sciences, Howard University, Washington, DC, United States
| | - Cynthia Eileen Winston-Proctor
- Department of Psychology, Howard University, Washington, DC, United States.,College of Arts & Sciences, Graduate School of Arts & Sciences, Howard University, Washington, DC, United States
| | | | - Jason M Jones
- Department of Psychological Sciences, Winston-Salem State University, Winston-Salem, NC, United States
| |
Collapse
|
9
|
Litton JK, Beck JT, Jones JM, Andersen J, Blum JL, Mina LA, Brig R, Danso MA, Yuan Y, Abbattista A, Noonan K, Chakrabarti J, Czibere A, Symmans WF, Telli ML. Neoadjuvant talazoparib in patients with germline BRCA1/2 (gBRCA1/2) mutation-positive, early HER2-negative breast cancer (BC): Results of a phase 2 study. J Clin Oncol 2021. [DOI: 10.1200/jco.2021.39.15_suppl.505] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
505 Background: Talazoparib (TALA) is a poly(ADP-ribose) polymerase inhibitor approved as monotherapy for treating adult patients (pts) with g BRCA1/2-mutated HER2-negative locally advanced or metastatic BC. Methods: This phase 2, non-randomized, single-arm, open-label study (NCT03499353) evaluated the efficacy and safety of TALA in the neoadjuvant setting for pts with early g BRCA1/2-mutated HER2− BC. Primary endpoint was evaluation of pathologic complete response (pCR) as assessed by Independent Central Review (ICR) after completing 24 weeks of neoadjuvant TALA monotherapy 1 mg QD (0.75 mg for moderate renal impairment) followed by surgery. Secondary endpoints included pCR by investigator (INV) and residual cancer burden (RCB) by ICR (RCB: 0 [pCR], I [minimal], II [moderate], III [extensive]). The evaluable population included pts who received at least 80% of the TALA dose prescribed at treatment start and underwent breast surgery and pCR assessment, plus those who progressed before pCR could be assessed. The intent-to-treat (ITT) population included all pts who received at least 1 dose of TALA. Results: Of 61 pts treated with TALA (ITT and safety populations), 48 comprised the evaluable population. All pts had triple-negative BC. 60 pts had adenocarcinoma and 1 had squamous cell histology, with the following staging: I=20, II=27, III=14. Mean age was 44.6 years, mean duration of 4.5 wks since disease onset, mean duration of treatment of 23.3 wks, and mean overall relative dose intensity of 84.5% (ITT population). pCR (assessed by ICR and INV) and RCB (by ICR) for the evaluable and ITT populations are shown in the table below. Ten (16.4%) patients discontinued treatment due to progressive disease. One pt had a disruption of treatment as a result of COVID-19 restrictions, 2 pts for other reasons: to undergo surgery early and consent withdrawal; 9 patients received <80% dose. Treatment-emergent adverse events (AEs) were reported in 98.4% of pts (27.9% grade [G] 1, 23.0% G2, 45.9% G3, 1.6% G4); the most common were fatigue (78.7%; G1 54.1%; G2 21.3%; G3 3.3%), nausea (68.9%; G1 54.1%; G2 13.1%; G3 1.6%), and alopecia (57.4%; G1 54.1%; G2 3.3%). Three (4.9%) pts discontinued treatment due to AEs (G3 anemia [n=2] and G3 vertigo [n=1]) and continued on study. Conclusions: TALA monotherapy in the neoadjuvant setting was active and showed pCR rates comparable to those observed with combination anthracycline and taxane-based chemotherapy regimens and was generally well tolerated. Clinical trial information: NCT03499353. [Table: see text]
Collapse
Affiliation(s)
| | | | | | - Jay Andersen
- Compass Oncology, West Cancer Center, Tigard, OR
| | - Joanne Lorraine Blum
- Texas Oncology–Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, TX
| | | | - Raymond Brig
- Brig Center for Cancer Care and Survivorship, Knoxville, TN
| | | | - Yuan Yuan
- City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA
| | | | | | | | | | | | | |
Collapse
|
10
|
Telli ML, Litton JK, Beck JT, Jones JM, Andersen J, Mina LA, Brig R, Danso MA, Yuan Y, Symmans WF, Abbattista A, Noonan K, Mata M, Laird D, Blum JL. Neoadjuvant talazoparib (TALA) in patients (pts) with germline BRCA1/2 (g BRCA1/2) mutation-positive, early HER2-negative breast cancer (BC): Exploration of tumor BRCA mutational status and zygosity and overall mutational landscape in a phase 2 study. J Clin Oncol 2021. [DOI: 10.1200/jco.2021.39.15_suppl.554] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
554 Background: TALA is a poly(ADP-ribose) polymerase inhibitor approved as monotherapy for adult pts with g BRCA1/2-mutated HER2-negative locally advanced/metastatic BC. We report biomarker analyses from a phase 2, nonrandomized, single-arm, open-label study (NEOTALA; NCT03499353) evaluating the efficacy and safety of TALA in the neoadjuvant setting for pts with early g BRCA1/2-mutated HER2− BC. Efficacy and safety results are presented separately. Methods: The biomarker analysis population was all pts treated with TALA for whom biomarker results are available. To support molecular eligibility, blood was tested using BRCAnalysis CDx (Myriad Genetics). Baseline tumor tissue was retrospectively tested using FoundationOne CDx, with BRCA1/2 zygosity assessed using somatic-germline-zygosity (SGZ; Sun et al. JCO PO, 2018). Germline mutational status of 14 non- BRCA DNA damage response (DDR) genes was retrospectively assessed in baseline saliva samples using Ambry CustomNext-Cancer. Mutations were defined as known/likely pathogenic/deleterious variants, including copy number alterations (CNAs). Association between mutational status of MYC or RAD21 and primary endpoint pathological complete response (pCR) as per Independent Central Review was investigated with logistic regression. Results: Of 52 evaluable tumor samples from 61 treated pts, 39 (75%) and 13 (25%) pts exhibited BRCA1 and BRCA2 mutations, respectively; 1 (2%) pt exhibited mutations in both genes, and 1 (2%) pt had mutations in neither. BRCA loss of heterozygosity (LOH) was seen in 42/43 (98%) evaluable BRCA-mutant tumors. Of 45 pts evaluable centrally for both germline and tumor, 44/45 (98%) pts exhibited the same BRCA mutation in tumor as originally detected in germline, with the remaining pt exhibiting a g BRCA1 mutation, but lacking a tumor BRCA mutation. None of 49 saliva-evaluable pts exhibited non- BRCA germline DDR mutations. TP53 (51 [98%] pts) was the most frequently mutated gene in tumors. MYC and RAD21 (each 14 [27%] pts) were the most frequent CNAs. No evidence of association between mutational status of MYC or RAD21 and pCR was found (odds ratio=0.39, 95% CI 0.12-2.30). Based on a cutoff of ≥16%, genomic LOH was elevated in 24/27 (89%) tumors evaluable for both gLOH and pCR, precluding assessment of the potential association of gLOH high/low status with pCR. Conclusions: Tumor BRCA mutations were evident in nearly all pts in the biomarker analysis population, with BRCA LOH evident in all but 1 BRCA-mutated tumor. No pts had non- BRCA germline DDR gene mutations; tumor TP53 mutations were near-universal. MYC and RAD21 each exhibited CNAs in 27% of tumors, with no association with pCR. These results support the central role of BRCA mutations in tumor pathobiology in this indication. Clinical trial information: NCT03499353.
Collapse
Affiliation(s)
| | | | | | | | - Jay Andersen
- Compass Oncology, West Cancer Center, Tigard, OR
| | | | - Raymond Brig
- Brig Center for Cancer Care and Survivorship, Knoxville, TN
| | | | - Yuan Yuan
- City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA
| | | | | | | | | | | | - Joanne Lorraine Blum
- Texas Oncology–Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, TX
| |
Collapse
|
11
|
Holding ML, Strickland JL, Rautsaw RM, Hofmann EP, Mason AJ, Hogan MP, Nystrom GS, Ellsworth SA, Colston TJ, Borja M, Castañeda-Gaytán G, Grünwald CI, Jones JM, Freitas-de-Sousa LA, Viala VL, Margres MJ, Hingst-Zaher E, Junqueira-de-Azevedo ILM, Moura-da-Silva AM, Grazziotin FG, Gibbs HL, Rokyta DR, Parkinson CL. Phylogenetically diverse diets favor more complex venoms in North American pitvipers. Proc Natl Acad Sci U S A 2021; 118:e2015579118. [PMID: 33875585 PMCID: PMC8092465 DOI: 10.1073/pnas.2015579118] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
Abstract
The role of natural selection in the evolution of trait complexity can be characterized by testing hypothesized links between complex forms and their functions across species. Predatory venoms are composed of multiple proteins that collectively function to incapacitate prey. Venom complexity fluctuates over evolutionary timescales, with apparent increases and decreases in complexity, and yet the causes of this variation are unclear. We tested alternative hypotheses linking venom complexity and ecological sources of selection from diet in the largest clade of front-fanged venomous snakes in North America: the rattlesnakes, copperheads, cantils, and cottonmouths. We generated independent transcriptomic and proteomic measures of venom complexity and collated several natural history studies to quantify dietary variation. We then constructed genome-scale phylogenies for these snakes for comparative analyses. Strikingly, prey phylogenetic diversity was more strongly correlated to venom complexity than was overall prey species diversity, specifically implicating prey species' divergence, rather than the number of lineages alone, in the evolution of complexity. Prey phylogenetic diversity further predicted transcriptomic complexity of three of the four largest gene families in viper venom, showing that complexity evolution is a concerted response among many independent gene families. We suggest that the phylogenetic diversity of prey measures functionally relevant divergence in the targets of venom, a claim supported by sequence diversity in the coagulation cascade targets of venom. Our results support the general concept that the diversity of species in an ecological community is more important than their overall number in determining evolutionary patterns in predator trait complexity.
Collapse
Affiliation(s)
- Matthew L Holding
- Department of Biological Sciences, Clemson University, Clemson, SC 29634;
- Department of Biological Science, Florida State University, Tallahassee, FL 32306
| | - Jason L Strickland
- Department of Biological Sciences, Clemson University, Clemson, SC 29634
| | - Rhett M Rautsaw
- Department of Biological Sciences, Clemson University, Clemson, SC 29634
| | - Erich P Hofmann
- Department of Biological Sciences, Clemson University, Clemson, SC 29634
| | - Andrew J Mason
- Department of Biological Sciences, Clemson University, Clemson, SC 29634
- Department of Evolution, Ecology and Organismal Biology, The Ohio State University, Columbus, OH 43210
| | - Michael P Hogan
- Department of Biological Science, Florida State University, Tallahassee, FL 32306
| | - Gunnar S Nystrom
- Department of Biological Science, Florida State University, Tallahassee, FL 32306
| | - Schyler A Ellsworth
- Department of Biological Science, Florida State University, Tallahassee, FL 32306
| | - Timothy J Colston
- Department of Biological Science, Florida State University, Tallahassee, FL 32306
| | - Miguel Borja
- Facultad de Ciencias Biológicas, Universidad Juárez del Estado de Durango, C.P. 35010 Gómez Palacio, Dgo., Mexico
| | - Gamaliel Castañeda-Gaytán
- Facultad de Ciencias Biológicas, Universidad Juárez del Estado de Durango, C.P. 35010 Gómez Palacio, Dgo., Mexico
| | | | - Jason M Jones
- HERP.MX A.C., Villa del Álvarez, Colima 28973, Mexico
| | | | - Vincent Louis Viala
- Laboratório de Toxinologia Aplicada, Instituto Butantan, São Paulo 05503-900, Brazil
- Center of Toxins, Immune-Response and Cell Signaling, São Paulo 05503-900, Brazil
| | - Mark J Margres
- Department of Biological Sciences, Clemson University, Clemson, SC 29634
- Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138
| | | | - Inácio L M Junqueira-de-Azevedo
- Laboratório de Toxinologia Aplicada, Instituto Butantan, São Paulo 05503-900, Brazil
- Center of Toxins, Immune-Response and Cell Signaling, São Paulo 05503-900, Brazil
| | - Ana M Moura-da-Silva
- Laboratório de Imunopatologia, Instituto Butantan, São Paulo 05503-900, Brazil
- Instituto de Pesquisa Clínica Carlos Borborema, Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus 69040, Brazil
| | - Felipe G Grazziotin
- Laboratório de Coleções Zoológicas, Instituto Butantan, São Paulo 05503-900, Brazil
| | - H Lisle Gibbs
- Department of Evolution, Ecology and Organismal Biology, The Ohio State University, Columbus, OH 43210
| | - Darin R Rokyta
- Department of Biological Science, Florida State University, Tallahassee, FL 32306
| | - Christopher L Parkinson
- Department of Biological Sciences, Clemson University, Clemson, SC 29634;
- Department of Forestry and Environmental Conservation, Clemson University, Clemson, SC 29634
| |
Collapse
|
12
|
Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Christensen A, Collister R, Mathad AC, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Grandemange P, Granum P, Hangst JS, Hardy WN, Hayden ME, Hodgkinson D, Hunter E, Isaac CA, Johnson MA, Jones JM, Jones SA, Jonsell S, Khramov A, Knapp P, Kurchaninov L, Madsen N, Maxwell D, McKenna JTK, Menary S, Michan JM, Momose T, Mullan PS, Munich JJ, Olchanski K, Olin A, Peszka J, Powell A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, Starko DM, So C, Stutter G, Tharp TD, Thibeault A, Thompson RI, van der Werf DP, Wurtele JS. Laser cooling of antihydrogen atoms. Nature 2021; 592:35-42. [PMID: 33790445 PMCID: PMC8012212 DOI: 10.1038/s41586-021-03289-6] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Accepted: 01/26/2021] [Indexed: 11/08/2022]
Abstract
The photon-the quantum excitation of the electromagnetic field-is massless but carries momentum. A photon can therefore exert a force on an object upon collision1. Slowing the translational motion of atoms and ions by application of such a force2,3, known as laser cooling, was first demonstrated 40 years ago4,5. It revolutionized atomic physics over the following decades6-8, and it is now a workhorse in many fields, including studies on quantum degenerate gases, quantum information, atomic clocks and tests of fundamental physics. However, this technique has not yet been applied to antimatter. Here we demonstrate laser cooling of antihydrogen9, the antimatter atom consisting of an antiproton and a positron. By exciting the 1S-2P transition in antihydrogen with pulsed, narrow-linewidth, Lyman-α laser radiation10,11, we Doppler-cool a sample of magnetically trapped antihydrogen. Although we apply laser cooling in only one dimension, the trap couples the longitudinal and transverse motions of the anti-atoms, leading to cooling in all three dimensions. We observe a reduction in the median transverse energy by more than an order of magnitude-with a substantial fraction of the anti-atoms attaining submicroelectronvolt transverse kinetic energies. We also report the observation of the laser-driven 1S-2S transition in samples of laser-cooled antihydrogen atoms. The observed spectral line is approximately four times narrower than that obtained without laser cooling. The demonstration of laser cooling and its immediate application has far-reaching implications for antimatter studies. A more localized, denser and colder sample of antihydrogen will drastically improve spectroscopic11-13 and gravitational14 studies of antihydrogen in ongoing experiments. Furthermore, the demonstrated ability to manipulate the motion of antimatter atoms by laser light will potentially provide ground-breaking opportunities for future experiments, such as anti-atomic fountains, anti-atom interferometry and the creation of antimatter molecules.
Collapse
Affiliation(s)
- C J Baker
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - W Bertsche
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Cockcroft Institute, Sci-Tech Daresbury, Warrington, UK
| | - A Capra
- TRIUMF, Vancouver, British Columbia, Canada
| | - C Carruth
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - C L Cesar
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - M Charlton
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - A Christensen
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | | | - A Cridland Mathad
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - S Eriksson
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - A Evans
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - N Evetts
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - J Fajans
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - T Friesen
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | | | - D R Gill
- TRIUMF, Vancouver, British Columbia, Canada
| | - P Grandemange
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - P Granum
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - J S Hangst
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark.
| | - W N Hardy
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - M E Hayden
- Department of Physics, Simon Fraser University, Burnaby, British Columbia, Canada
| | - D Hodgkinson
- School of Physics and Astronomy, University of Manchester, Manchester, UK
| | - E Hunter
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - C A Isaac
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - M A Johnson
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Cockcroft Institute, Sci-Tech Daresbury, Warrington, UK
| | - J M Jones
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - S A Jones
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - S Jonsell
- Department of Physics, Stockholm University, Stockholm, Sweden
| | - A Khramov
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
- Department of Physics, British Columbia Institute of Technology, Burnaby, British Columbia, Canada
| | - P Knapp
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | | | - N Madsen
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - D Maxwell
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - J T K McKenna
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - S Menary
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - J M Michan
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - T Momose
- TRIUMF, Vancouver, British Columbia, Canada.
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada.
| | - P S Mullan
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - J J Munich
- Department of Physics, Simon Fraser University, Burnaby, British Columbia, Canada
| | | | - A Olin
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - J Peszka
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - A Powell
- Department of Physics, College of Science, Swansea University, Swansea, UK
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - P Pusa
- Department of Physics, University of Liverpool, Liverpool, UK
| | - C Ø Rasmussen
- Experimental Physics Department, CERN, Geneva, Switzerland
| | - F Robicheaux
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN, USA
| | - R L Sacramento
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - M Sameed
- School of Physics and Astronomy, University of Manchester, Manchester, UK
| | - E Sarid
- Soreq NRC, Yavne, Israel
- Department of Physics, Ben Gurion University, Beer Sheva, Israel
| | - D M Silveira
- TRIUMF, Vancouver, British Columbia, Canada
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - D M Starko
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - C So
- TRIUMF, Vancouver, British Columbia, Canada
| | - G Stutter
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - T D Tharp
- Physics Department, Marquette University, Milwaukee, WI, USA
| | - A Thibeault
- TRIUMF, Vancouver, British Columbia, Canada
- Faculté de Génie, Université de Sherbrooke, Sherbrooke, Quebec, Canada
| | - R I Thompson
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - D P van der Werf
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - J S Wurtele
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| |
Collapse
|
13
|
Allen N, O'Sullivan K, Jones JM. The most influential papers in mitral valve surgery; a bibliometric analysis. J Cardiothorac Surg 2020; 15:175. [PMID: 32690042 PMCID: PMC7370429 DOI: 10.1186/s13019-020-01214-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2019] [Accepted: 07/01/2020] [Indexed: 12/02/2022] Open
Abstract
This study is an analysis of the 100 most cited articles in mitral valve surgery. A bibliometric analysis is a tool to evaluate research performance in a given field. It uses the number of times a publication is cited by others as a proxy marker of its impact. The most cited paper Carpentier et al. discusses mitral valve repair in terms of restoring the geometry of the entire valve rather than simply narrowing the annulus (Carpentier, J Thorac Cardiovasc Surg 86:23–37, 1983). The first successful mitral valve repair was performed by Elliot Cutler at Brigham and Women’s Hospital in 1923 (Cohn et al., Ann Cardiothorac Surg 4:315, 2015). More recently percutaneous and minimally invasive techniques that were originally designed as an option for high risk patients are being trialled in other patient groups (Hajar, Heart Views 19:160–3, 2018). Comparison of percutaneous method with open repair represents an expanding area of research (Hajar, Heart Views 19:160–3, 2018). This study will analyse the top 100 cited papers relevant to mitral valve surgery, identifying the most influential papers that guide current management, the institutions that produce them and the authors involved.
Collapse
Affiliation(s)
- N Allen
- Department of Cardiothoracic Surgery, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, BT12 6BA, UK.
| | - K O'Sullivan
- Department of Cardiothoracic Surgery, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, BT12 6BA, UK
| | - J M Jones
- Department of Cardiothoracic Surgery, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, BT12 6BA, UK
| |
Collapse
|
14
|
Grünwald CI, Franz-Chávez H, Morales-Flores KI, Ahumada-Carrillo IT, Jones JM. A rare new treefrog of the genus Sarcohyla (Anura: Hylidae) from Guerrero, Mexico. Zootaxa 2019; 4712:zootaxa.4712.3.2. [PMID: 32230674 DOI: 10.11646/zootaxa.4712.3.2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2019] [Indexed: 11/04/2022]
Abstract
Based on morphological data collected from treefrogs related to Sarcohyla hazelae, we describe a new species of the genus Sarcohyla from the cloud forest of the Sierra Madre del Sur of Guerrero, Mexico. We compare physical charactersitics of this new species to its closest relatives within the genus Sarcohyla, including dorsal and ventral coloration, head shape, tympanum distinctiveness, morphometrics and the condition of the tubercles on hands and feet. We analyze accoustic data from the advertisement call of males of the new species. We discuss the relationship of the species described herein with several of its cogeners, plus we resurrect the Sarcohyla hazelae group for these frogs. We describe habitat and distribution species related to Sarcohyla hazelae and also comment on the conservation priorities of these frogs.
Collapse
Key Words
- Amphibia, Anura, Conservation, Cloud forest, Guerrero, Hylidae, New species, Oaxaca, Sarcohyla hazelae, Sarcohyla thorectes, Sarcohyla toyota sp. nov., Sierra Madre del Sur, Taxonomy, Toyota, Treefrogs
Collapse
Affiliation(s)
- Christoph I Grünwald
- Biencom Real Estate, Carretera Chapala-Jocotepec #57-1, C.P. 45920, Ajijic, Jalisco, Mexico. Biodiversa A.C., Avenida de la Ribera #203, C.P. 45900, Chapala, Jalisco, Mexico. Herp.mx A.C. Villa de Alvarez, Colima, Mexico..
| | | | | | | | | |
Collapse
|
15
|
Gul SS, Cohen SA, Becker TK, Huesgen K, Jones JM, Tyndall JA. Patient, Neighborhood, and Spatial Determinants of Out-of-Hospital Cardiac Arrest Outcomes Throughout the Chain of Survival: A Community-Oriented Multilevel Analysis. PREHOSP EMERG CARE 2019; 24:307-318. [PMID: 31287347 DOI: 10.1080/10903127.2019.1640324] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Objective: Global and national trends of out-of-hospital cardiac arrest (OHCA) have been examined; however, geographic variation and socioeconomic disparities of OHCA outcomes in the community setting are less understood. We developed and tested a replicable, community-oriented assessment strategy aimed to identify spatial variations in OHCA outcomes using socioeconomic, prehospital, and in-hospital factors. Methods: Emergency medical service (EMS) records of adult, non-traumatic OHCA within Alachua County, FL (2012-2017) were retrospectively reviewed and matched to corresponding medical records at the University of Florida (UF). Incidence of cardiac arrest was geocoded to census tracts and connected to U.S. census socioeconomic attribute data. Primary outcomes include survival to emergency department (ED), hospital admission, discharge, and discharge to home. Multilevel mixed-effects logistic regression models were developed to assess sub-county geographic variance, probabilities of survival, and prehospital risk factors. Getis-Ord Gi statistic and Moran's I-test was applied to assess spatial clustering in outcome survival rates. Results: Of the 1562 OHCA cases extracted from EMS records, 1,335 (85.5%) were included with 372 transported to study site. Predicted probability of survival to ED was 57.0% (95CI: 51.3-62.3%). Of transported cases to study site ED, predicted probabilities of survival was to 41.7% (95CI: 36.1-47.6%) for hospital admission, 16.1% (95CI: 10.7-23.5%) for hospital discharge, and 7.1% (95CI: 3.7-13.3%) for home discharge. Census tracts accounted for significant variability in survival to ED (p < 0.001), discharge (p = 0.031), and home discharge outcomes (p = 0.036). There was no significant geographic variation in survival to admission outcome. Neighborhood-level factors significantly improved model fit for survival to ED, discharge, and discharge home outcomes. Multiple modifiable patient- and neighborhood-level variables of interest were identified, including rural-urban differences. Conclusion: We identified important geographic disparities that exist in OHCA outcomes at the community level. By using a replicable schematic, this variation can be explained through community-oriented modifiable socioeconomic and prehospital factors.
Collapse
|
16
|
Hwang CW, Fitzpatrick DE, Becker TK, Jones JM. Paramedic determination of appropriate emergency department destination. Am J Emerg Med 2019; 37:482-485. [DOI: 10.1016/j.ajem.2018.06.024] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2018] [Revised: 06/11/2018] [Accepted: 06/11/2018] [Indexed: 11/29/2022] Open
|
17
|
Bernstein LJ, D'Amico DN, Richard NM, McCready DR, Howell D, Jones JM, Edelstein K. Abstract PD6-01: Prevalence and predictors of self-reported memory ability in a large sample of breast cancer survivors. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-pd6-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: A substantial subset of women previously treated for breast cancer report deficits in cognitive abilities such as memory. Cancer-related cognitive dysfunction (CRCD) has been linked to a variety of factors including chemotherapy. However, the reported prevalence of symptoms is variable and investigations of CRCD correlates in large samples are limited. This study aimed to 1) investigate whether the prevalence of patient-reported memory problems differs as a function of having received chemotherapy and time-since-treatment; and 2) identify additional factors associated with patient-reported memory in a large sample of breast cancer survivors.
Method: In this cross-sectional cohort study, self-administered questionnaires including those assessing memory (Multifactorial Memory Questionnaire) and lifestyle behaviors were mailed to 1500 disease-free breast cancer survivors from three time-since-treatment cohorts (early: 6-18 months, middle: 2-4 years, or late: 5-12 years post-treatment). Demographic and clinical information was collected and confirmed from chart review. The prevalence of clinically significant memory dysfunction was estimated using published normative cut-off scores. We tested whether chemotherapy and time-since-treatment affected memory (analysis of variance), or increased the risk of significant memory dysfunction (odds ratio chi-squared test). Using a forward stepwise regression model, we explored whether patient characteristics (age, education, comorbidities, concussion history, adverse life events), type of treatment (chemotherapy, radiotherapy, hormonal therapy), or lifestyle behaviors (adherence to a Mediterranean diet, physical activity, sleep efficiency, stress management practices) were associated with patient-reported memory.
Results: 773 questionnaire packages were returned (mean age=60.4±11.7). 436 (56%) survivors had received chemotherapy (Ch+), and 337 (44%) had not (Ch-). 314 (41%) were early survivors, 244 (32%) were middle, and 215 (28%) were late. Ch+ reported poorer memory than Ch- (F(1, 764)=12.752, p<0.001), with no effect of time-since-treatment or interaction. Prevalence of significant memory dysfunction was higher in Ch+ (28%) than in Ch- (15%) (OR=2.130, 95% CI 1.479-3.066). Younger age and history of concussion were significantly associated with worse patient-reported memory (p=0.002, p<0.001). Unlike chemotherapy (p=0.018), neither radiation nor hormonal treatment was a significant predictor of memory symptoms. Increased physical activity (p=0.002) and higher sleep efficiency (p<0.001) were associated with better memory. Survivors reporting greater memory symptoms also reported greater use of stress management techniques (p=0.026).
Conclusion: This large study indicates that chemotherapy doubles the risk of memory symptoms up to at least 10 years post-treatment. Results also point to sleep hygiene and physical activity as potentially meaningful targets for self-management training to reduce CRCD in breast cancer survivors.
Citation Format: Bernstein LJ, D'Amico DN, Richard NM, McCready DR, Howell D, Jones JM, Edelstein K. Prevalence and predictors of self-reported memory ability in a large sample of breast cancer survivors [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr PD6-01.
Collapse
Affiliation(s)
- LJ Bernstein
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; University of Toronto, Toronto, Canada; Ryerson University, Toronto, Canada
| | - DN D'Amico
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; University of Toronto, Toronto, Canada; Ryerson University, Toronto, Canada
| | - NM Richard
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; University of Toronto, Toronto, Canada; Ryerson University, Toronto, Canada
| | - DR McCready
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; University of Toronto, Toronto, Canada; Ryerson University, Toronto, Canada
| | - D Howell
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; University of Toronto, Toronto, Canada; Ryerson University, Toronto, Canada
| | - JM Jones
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; University of Toronto, Toronto, Canada; Ryerson University, Toronto, Canada
| | - K Edelstein
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; University of Toronto, Toronto, Canada; Ryerson University, Toronto, Canada
| |
Collapse
|
18
|
Fong AJ, Jones JM, Faulkner G, Sabiston CM. Exploring cancer centres for physical activity and sedentary behaviour support for breast cancer survivors. ACTA ACUST UNITED AC 2018; 25:e365-e372. [PMID: 30464686 DOI: 10.3747/co.25.3858] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background Up to 90% of breast cancer survivors report low levels of physical activity (pa) and spend approximately 70% of the day in sedentary behaviour. Survivors might not be receiving information about the health benefits of pa and the consequences of sedentary behaviour in the context of their cancer. The primary purpose of the present study was to evaluate cancer centres for pa and sedentary behaviour information and infrastructure. A secondary aim was to evaluate the quality of the information that is accessible to breast cancer survivors in cancer centres. Methods A built-environment scan of the 14 regional cancer centres in Ontario and an evaluation of the text materials about pa available at the cancer centres were completed. Data analyses included descriptive statistics, proportions, and inter-rater reliability. Results The infrastructure of the cancer centres provided few opportunities for dissemination of information related to pa through signs and printed notices. Televisions were present in all waiting rooms, which could provide a unique opportunity for dissemination of information about pa and sedentary behaviour. Text materials were rated as trustworthy, used some behaviour change techniques (for example, information about the consequences of lack of pa, barrier identification, and setting graded tasks), and were aesthetically pleasing. Conclusions These findings represent areas for knowledge dissemination both for the centre and for resources that could be further improved.
Collapse
Affiliation(s)
- A J Fong
- At the time of the study: Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, ON; currently: School of Kinesiology and Health Studies, Queen's University, Kingston, ON
| | - J M Jones
- Cancer Rehabilitation and Survivorship Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON
| | - G Faulkner
- School of Kinesiology, University of British Columbia, Vancouver, BC
| | - C M Sabiston
- Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, ON
| |
Collapse
|
19
|
Ahmadi M, Alves BXR, Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Cohen S, Collister R, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Hangst JS, Hardy WN, Hayden ME, Hunter ED, Isaac CA, Johnson MA, Jones JM, Jones SA, Jonsell S, Khramov A, Knapp P, Kurchaninov L, Madsen N, Maxwell D, McKenna JTK, Menary S, Michan JM, Momose T, Munich JJ, Olchanski K, Olin A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, Starko DM, Stutter G, So C, Tharp TD, Thompson RI, van der Werf DP, Wurtele JS. Observation of the 1S-2P Lyman-α transition in antihydrogen. Nature 2018; 561:211-215. [PMID: 30135588 PMCID: PMC6786973 DOI: 10.1038/s41586-018-0435-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2018] [Accepted: 07/05/2018] [Indexed: 11/09/2022]
Abstract
In 1906, Theodore Lyman discovered his eponymous series of transitions in the extreme-ultraviolet region of the atomic hydrogen spectrum1,2. The patterns in the hydrogen spectrum helped to establish the emerging theory of quantum mechanics, which we now know governs the world at the atomic scale. Since then, studies involving the Lyman-α line-the 1S-2P transition at a wavelength of 121.6 nanometres-have played an important part in physics and astronomy, as one of the most fundamental atomic transitions in the Universe. For example, this transition has long been used by astronomers studying the intergalactic medium and testing cosmological models via the so-called 'Lyman-α forest'3 of absorption lines at different redshifts. Here we report the observation of the Lyman-α transition in the antihydrogen atom, the antimatter counterpart of hydrogen. Using narrow-line-width, nanosecond-pulsed laser radiation, the 1S-2P transition was excited in magnetically trapped antihydrogen. The transition frequency at a field of 1.033 tesla was determined to be 2,466,051.7 ± 0.12 gigahertz (1σ uncertainty) and agrees with the prediction for hydrogen to a precision of 5 × 10-8. Comparisons of the properties of antihydrogen with those of its well-studied matter equivalent allow precision tests of fundamental symmetries between matter and antimatter. Alongside the ground-state hyperfine4,5 and 1S-2S transitions6,7 recently observed in antihydrogen, the Lyman-α transition will permit laser cooling of antihydrogen8,9, thus providing a cold and dense sample of anti-atoms for precision spectroscopy and gravity measurements10. In addition to the observation of this fundamental transition, this work represents both a decisive technological step towards laser cooling of antihydrogen, and the extension of antimatter spectroscopy to quantum states possessing orbital angular momentum.
Collapse
Affiliation(s)
- M Ahmadi
- Department of Physics, University of Liverpool, Liverpool, UK
| | - B X R Alves
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - C J Baker
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - W Bertsche
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Cockcroft Institute, Sci-Tech Daresbury, Warrington, UK
| | - A Capra
- TRIUMF, Vancouver, British Columbia, Canada
| | - C Carruth
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - C L Cesar
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - M Charlton
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - S Cohen
- Department of Physics, Ben-Gurion University of the Negev, Beer-Sheva, Israel
| | | | - S Eriksson
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - A Evans
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - N Evetts
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - J Fajans
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - T Friesen
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | | | - D R Gill
- TRIUMF, Vancouver, British Columbia, Canada
| | - J S Hangst
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark.
| | - W N Hardy
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - M E Hayden
- Department of Physics, Simon Fraser University, Burnaby, British Columbia, Canada
| | - E D Hunter
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - C A Isaac
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - M A Johnson
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Cockcroft Institute, Sci-Tech Daresbury, Warrington, UK
| | - J M Jones
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - S A Jones
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - S Jonsell
- Department of Physics, Stockholm University, Stockholm, Sweden
| | - A Khramov
- TRIUMF, Vancouver, British Columbia, Canada
| | - P Knapp
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | | | - N Madsen
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - D Maxwell
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | | | - S Menary
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - J M Michan
- TRIUMF, Vancouver, British Columbia, Canada
- École Polytechnique Fédérale de Lausanne (EPFL), Swiss Plasma Center (SPC), Lausanne, Switzerland
| | - T Momose
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada.
| | - J J Munich
- Department of Physics, Simon Fraser University, Burnaby, British Columbia, Canada
| | | | - A Olin
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - P Pusa
- Department of Physics, University of Liverpool, Liverpool, UK
| | - C Ø Rasmussen
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - F Robicheaux
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN, USA
| | - R L Sacramento
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - M Sameed
- School of Physics and Astronomy, University of Manchester, Manchester, UK
| | | | - D M Silveira
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - D M Starko
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - G Stutter
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - C So
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - T D Tharp
- Physics Department, Marquette University, Milwaukee, WI, USA
| | - R I Thompson
- TRIUMF, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - D P van der Werf
- Department of Physics, College of Science, Swansea University, Swansea, UK
- IRFU, CEA/Saclay, Gif-sur-Yvette Cedex, France
| | - J S Wurtele
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| |
Collapse
|
20
|
Ahmadi M, Alves BXR, Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Cohen S, Collister R, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Hangst JS, Hardy WN, Hayden ME, Isaac CA, Johnson MA, Jones JM, Jones SA, Jonsell S, Khramov A, Knapp P, Kurchaninov L, Madsen N, Maxwell D, McKenna JTK, Menary S, Momose T, Munich JJ, Olchanski K, Olin A, Pusa P, Rasmussen CØ, Robicheaux F, Sacramento RL, Sameed M, Sarid E, Silveira DM, Stutter G, So C, Tharp TD, Thompson RI, van der Werf DP, Wurtele JS. Characterization of the 1S-2S transition in antihydrogen. Nature 2018; 557:71-75. [PMID: 29618820 PMCID: PMC6784861 DOI: 10.1038/s41586-018-0017-2] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2017] [Accepted: 03/06/2018] [Indexed: 11/09/2022]
Abstract
In 1928, Dirac published an equation 1 that combined quantum mechanics and special relativity. Negative-energy solutions to this equation, rather than being unphysical as initially thought, represented a class of hitherto unobserved and unimagined particles-antimatter. The existence of particles of antimatter was confirmed with the discovery of the positron 2 (or anti-electron) by Anderson in 1932, but it is still unknown why matter, rather than antimatter, survived after the Big Bang. As a result, experimental studies of antimatter3-7, including tests of fundamental symmetries such as charge-parity and charge-parity-time, and searches for evidence of primordial antimatter, such as antihelium nuclei, have high priority in contemporary physics research. The fundamental role of the hydrogen atom in the evolution of the Universe and in the historical development of our understanding of quantum physics makes its antimatter counterpart-the antihydrogen atom-of particular interest. Current standard-model physics requires that hydrogen and antihydrogen have the same energy levels and spectral lines. The laser-driven 1S-2S transition was recently observed 8 in antihydrogen. Here we characterize one of the hyperfine components of this transition using magnetically trapped atoms of antihydrogen and compare it to model calculations for hydrogen in our apparatus. We find that the shape of the spectral line agrees very well with that expected for hydrogen and that the resonance frequency agrees with that in hydrogen to about 5 kilohertz out of 2.5 × 1015 hertz. This is consistent with charge-parity-time invariance at a relative precision of 2 × 10-12-two orders of magnitude more precise than the previous determination 8 -corresponding to an absolute energy sensitivity of 2 × 10-20 GeV.
Collapse
Affiliation(s)
- M Ahmadi
- Department of Physics, University of Liverpool, Liverpool, UK
| | - B X R Alves
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - C J Baker
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - W Bertsche
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Cockcroft Institute, Sci-Tech Daresbury, Warrington, UK
| | - A Capra
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada
| | - C Carruth
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - C L Cesar
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - M Charlton
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - S Cohen
- Department of Physics, Ben-Gurion University of the Negev, Beer-Sheva, Israel
| | - R Collister
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada
| | - S Eriksson
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - A Evans
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - N Evetts
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - J Fajans
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| | - T Friesen
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - M C Fujiwara
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada
| | - D R Gill
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada
| | - J S Hangst
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark.
| | - W N Hardy
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - M E Hayden
- Department of Physics, Simon Fraser University, Burnaby, British Columbia, Canada
| | - C A Isaac
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - M A Johnson
- School of Physics and Astronomy, University of Manchester, Manchester, UK
- Cockcroft Institute, Sci-Tech Daresbury, Warrington, UK
| | - J M Jones
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - S A Jones
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - S Jonsell
- Department of Physics, Stockholm University, Stockholm, Sweden
| | - A Khramov
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada
| | - P Knapp
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - L Kurchaninov
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada
| | - N Madsen
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - D Maxwell
- Department of Physics, College of Science, Swansea University, Swansea, UK
| | - J T K McKenna
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada
| | - S Menary
- Department of Physics and Astronomy, York University, Toronto, Ontario, Canada
| | - T Momose
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
| | - J J Munich
- Department of Physics, Simon Fraser University, Burnaby, British Columbia, Canada
| | - K Olchanski
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada
| | - A Olin
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia, Canada
- Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada
| | - P Pusa
- Department of Physics, University of Liverpool, Liverpool, UK
| | - C Ø Rasmussen
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - F Robicheaux
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN, USA
| | - R L Sacramento
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - M Sameed
- Department of Physics, College of Science, Swansea University, Swansea, UK
- School of Physics and Astronomy, University of Manchester, Manchester, UK
| | | | - D M Silveira
- Instituto de Fisica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - G Stutter
- Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark
| | - C So
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - T D Tharp
- Physics Department, Marquette University, Milwaukee, WI, USA
| | - R I Thompson
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada
| | - D P van der Werf
- Department of Physics, College of Science, Swansea University, Swansea, UK
- IRFU, CEA/Saclay, Gif-sur-Yvette Cedex, France
| | - J S Wurtele
- Department of Physics, University of California at Berkeley, Berkeley, CA, USA
| |
Collapse
|
21
|
Mina DS, Sabiston CM, Au D, Fong AJ, Capozzi LC, Langelier D, Chasen M, Chiarotto J, Tomasone JR, Jones JM, Chang E, Culos-Reed SN. Connecting people with cancer to physical activity and exercise programs: a pathway to create accessibility and engagement. ACTA ACUST UNITED AC 2018; 25:149-162. [PMID: 29719431 DOI: 10.3747/co.25.3977] [Citation(s) in RCA: 91] [Impact Index Per Article: 15.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Recent guidelines concerning exercise for people with cancer provide evidence-based direction for exercise assessment and prescription for clinicians and their patients. Although the guidelines promote exercise integration into clinical care for people with cancer, they do not support strategies for bridging the guidelines with related resources or programs. Exercise program accessibility remains a challenge in implementing the guidelines, but that challenge might be mitigated with conceptual frameworks ("pathways") that connect patients with exercise-related resources. In the present paper, we describe a pathway model and related resources that were developed by an expert panel of practitioners and researchers in the field of exercise and rehabilitation in oncology and that support the transition from health care practitioner to exercise programs or services for people with cancer. The model acknowledges the nuanced distinctions between research and exercise programming, as well as physical activity promotion, that, depending on the available programming in the local community or region, might influence practitioner use. Furthermore, the pathway identifies and provides examples of processes for referral, screening, medical clearance, and programming for people after a cancer diagnosis. The pathway supports the implementation of exercise guidelines and should serve as a model of enhanced care delivery to increase the health and well-being of people with cancer.
Collapse
Affiliation(s)
- D Santa Mina
- Faculty of Kinesiology and Physical Education and.,Faculty of Medicine, University of Toronto, Toronto, ON.,Cancer Rehabilitation and Survivorship, Princess Margaret Cancer Centre, Toronto, ON
| | - C M Sabiston
- Faculty of Kinesiology and Physical Education and
| | - D Au
- Faculty of Kinesiology and Physical Education and.,Cancer Rehabilitation and Survivorship, Princess Margaret Cancer Centre, Toronto, ON
| | - A J Fong
- Faculty of Kinesiology and Physical Education and
| | - L C Capozzi
- Cumming School of Medicine, University of Calgary, Calgary, AB
| | - D Langelier
- Cumming School of Medicine, University of Calgary, Calgary, AB
| | - M Chasen
- Faculty of Kinesiology and Physical Education and
| | - J Chiarotto
- Department of Medicine, Scarborough and Rouge Hospital, Toronto, ON
| | - J R Tomasone
- School of Kinesiology and Health Studies, Queen's University, Kingston, ON
| | - J M Jones
- Faculty of Medicine, University of Toronto, Toronto, ON.,Cancer Rehabilitation and Survivorship, Princess Margaret Cancer Centre, Toronto, ON
| | - E Chang
- Faculty of Medicine, University of Toronto, Toronto, ON.,Cancer Rehabilitation and Survivorship, Princess Margaret Cancer Centre, Toronto, ON.,Toronto Rehabilitation Institute, Toronto, ON
| | - S N Culos-Reed
- Cumming School of Medicine, University of Calgary, Calgary, AB.,Faculty of Kinesiology, University of Calgary, Calgary, AB.,Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, AB
| |
Collapse
|
22
|
Naik H, Qiu X, Brown MC, Eng L, Pringle D, Mahler M, Hon H, Tiessen K, Thai H, Ho V, Gonos C, Charow R, Pat V, Irwin M, Herzog L, Ho A, Xu W, Jones JM, Howell D, Liu G. Socioeconomic status and lifestyle behaviours in cancer survivors: smoking and physical activity. ACTA ACUST UNITED AC 2016; 23:e546-e555. [PMID: 28050143 DOI: 10.3747/co.23.3166] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
PURPOSE Smoking cessation and increased physical activity (pa) have been linked to better outcomes in cancer survivors. We assessed whether socioeconomic factors influence changes in those behaviours after a cancer diagnosis. METHODS As part of a cross-sectional study, a diverse group of cancer survivors at the Princess Margaret Cancer Centre (Toronto, ON), completed a questionnaire about past and current lifestyle behaviours and perceptions about the importance of those behaviours with respect to their health. The influence of socioeconomic indicators on smoking status and physical inactivity at 1 year before and after diagnosis were assessed using multivariable logistic regression with adjustment for clinico-demographic factors. RESULTS Of 1222 participants, 1192 completed the smoking component. Of those respondents, 15% smoked before diagnosis, and 43% of those smokers continued to smoke after. The proportion of survivors who continued to smoke increased with lower education level (p = 0.03). Of the 1106 participants answering pa questions, 39% reported being physically inactive before diagnosis, of whom 82% remained inactive afterward. Survivors with a lower education level were most likely to remain inactive after diagnosis (p = 0.003). Lower education level, household income, and occupation were associated with the perception that pa had no effect or could worsen fatigue and quality of life (p ≤ 0.0001). CONCLUSIONS In cancer survivors, education level was a major modifier of smoking and pa behaviours. Lower socioeconomic status was associated with incorrect perceptions about pa. Targeting at-risk survivors by education level should be evaluated as a strategy in cancer survivorship programs.
Collapse
Affiliation(s)
- H Naik
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - X Qiu
- Biostatistics, Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - M C Brown
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - L Eng
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - D Pringle
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - M Mahler
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - H Hon
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - K Tiessen
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - H Thai
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - V Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - C Gonos
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - R Charow
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - V Pat
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - M Irwin
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - L Herzog
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - A Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - W Xu
- Biostatistics, Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - J M Jones
- Toronto General Research Institute, Toronto and
| | - D Howell
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto
| | - G Liu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto;; Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON
| |
Collapse
|
23
|
Abstract
BXSB mice, a murine model of systemic lupus erythematosus (SLE), were treated with two different doses of fludarabine for a four-week period and examined two weeks after the final dose. Control mice were treated with saline or cyclophosphamide. Mice treated with fludarabine had a significant reduction in renal pathology compared to control mice. Fludarabine-treated mice also had an almost 10-fold increase in percentile of CD8+CD25+ T cells in the spleen and a smaller but significant increase in CD4+CD25+ cells. Mice treated with cyclophosphamide had a greater leucopenia compared to the other groups and a significant reduction in percentile of B220+ cells in peripheral blood and spleen. Serum autoantibody levels to dsDNA did not differ significantly among the groups, but were higher in 4/10 mice treated with fludarabine. Although few trials of fludarabine for human SLE have been conducted, additional studies may be warranted.
Collapse
Affiliation(s)
- O Y Jones
- Department of Pediatrics, University of South Florida All Children's Hospital, St Petersburg, Florida 33701, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Phillips D, Mitchell EJS, Lea-Langton AR, Parmar KR, Jones JM, Williams A. The use of conservation biomass feedstocks as potential bioenergy resources in the United Kingdom. Bioresour Technol 2016; 212:271-279. [PMID: 27107483 DOI: 10.1016/j.biortech.2016.04.057] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/14/2016] [Revised: 04/11/2016] [Accepted: 04/12/2016] [Indexed: 06/05/2023]
Abstract
A number of countries have introduced energy policies to reduce the emission of carbon dioxide which, in the case of bio-heat, has resulted in increased use of small wood burning stoves and boilers, particularly in Europe. There are issues surrounding the supply of sustainable wood feedstock, prompting a desire to utilise local biomass resources. This includes biomass generated through the management of natural woodlands in nature reserves and conservation areas. These management practices can also extend to other areas, such as raised bog wildernesses and estuary Reed beds. We term the biomass from this resource as conservation biomass. This study is concerned with the viability of this resource as a fuel within the United Kingdom, and combustion tests were carried out using a small domestic stove. It was concluded that there is as much as 500kty(-1) that could be used in this way.
Collapse
Affiliation(s)
- D Phillips
- Energy Research Institute, School of Chemical and Process Engineering, The University of Leeds, LS29JT, UK
| | - E J S Mitchell
- Energy Research Institute, School of Chemical and Process Engineering, The University of Leeds, LS29JT, UK
| | - A R Lea-Langton
- School of Mechanical, Aerospace and Civil Engineering, The University of Manchester, Manchester M13 9PL, UK
| | - K R Parmar
- Energy Research Institute, School of Chemical and Process Engineering, The University of Leeds, LS29JT, UK
| | - J M Jones
- Energy Research Institute, School of Chemical and Process Engineering, The University of Leeds, LS29JT, UK
| | - A Williams
- Energy Research Institute, School of Chemical and Process Engineering, The University of Leeds, LS29JT, UK.
| |
Collapse
|
25
|
Leute J, Huntemann N, Lipphardt B, Tamm C, Nisbet-Jones PBR, King SA, Godun RM, Jones JM, Margolis HS, Whibberley PB, Wallin A, Merimaa M, Gill P, Peik E. Frequency Comparison of [Formula: see text] Ion Optical Clocks at PTB and NPL via GPS PPP. IEEE Trans Ultrason Ferroelectr Freq Control 2016; 63:981-985. [PMID: 26863657 DOI: 10.1109/tuffc.2016.2524988] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
We used precise point positioning, a well-established GPS carrier-phase frequency transfer method to perform a direct remote comparison of two optical frequency standards based on single laser-cooled [Formula: see text] ions operated at the National Physical Laboratory (NPL), U.K. and the Physikalisch-Technische Bundesanstalt (PTB), Germany. At both institutes, an active hydrogen maser serves as a flywheel oscillator which is connected to a GPS receiver as an external frequency reference and compared simultaneously to a realization of the unperturbed frequency of the (2)S1/2(F=0)-(2)D3/2(F=2) electric quadrupole transition in [Formula: see text] via an optical femtosecond frequency comb. To profit from long coherent GPS-link measurements, we extrapolate the fractional frequency difference over the various data gaps in the optical clock to maser comparisons which introduces maser noise to the frequency comparison but improves the uncertainty from the GPS-link instability. We determined the total statistical uncertainty consisting of the GPS-link uncertainty and the extrapolation uncertainties for several extrapolation schemes. Using the extrapolation scheme with the smallest combined uncertainty, we find a fractional frequency difference [Formula: see text] of -1.3×10(-15) with a combined uncertainty of 1.2×10(-15) for a total measurement time of 67 h. This result is consistent with an agreement of the frequencies realized by both optical clocks and with recent absolute frequency measurements against caesium fountain clocks within the corresponding uncertainties.
Collapse
|
26
|
Booth K, Beattie R, McBride M, Manoharan G, Spence M, Jones JM. High Risk Aortic Valve Replacement - The Challenges of Multiple Treatment Strategies with an Evolving Technology. Ulster Med J 2016; 85:18-22. [PMID: 27158160 PMCID: PMC4847840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
OBJECTIVES Deciding on the optimal treatment strategy for high risk aortic valve replacement is challenging. Transcatheter Aortic Valve implantation (TAVI) has been available in our centre as an alternative treatment modality for patients since 2008. We present our early experience of TAVI and SAVR (surgical Aortic Valve Replacement) in high risk patients who required SAVR because TAVI could not be performed. METHODS The database for Surgical aortic valve and Transcatheter aortic valve replacement referrals was interrogated to identify relevant patients. RESULTS Survival to hospital discharge was 95.5% in the forty five patients who had SAVR when TAVI was deemed technically unsuitable. One year survival was 86%. CONCLUSION Defining who is appropriate for TAVI or high risk SAVR is challenging and multidisciplinary team discussion has never been more prudent in this field of evolving technology with ever decreasing risks of surgery. The introduction of TAVI at our institution has seen a rise in our surgical caseload by approximately by 25%. Overall, the option of aortic valve intervention is being offered to more patients in general which is a substantial benefit in the treatment of aortic valve disease.
Collapse
Affiliation(s)
- K Booth
- Department of Cardiothoracic Surgery, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, BT12 6BA
| | - R Beattie
- Department of Cardiothoracic Surgery, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, BT12 6BA
| | - M McBride
- Department of Cardiothoracic Surgery, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, BT12 6BA
| | - G Manoharan
- Department of Cardiology, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, BT12 6BA
| | - M Spence
- Department of Cardiology, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, BT12 6BA
| | - J M Jones
- Department of Cardiothoracic Surgery, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, BT12 6BA
| |
Collapse
|
27
|
Macdougall IC, Jones JM, Robinson MI, Miles JB, Coles GA, Williams JD. Subcutaneous erythropoietin therapy: comparison of three different sites of injection. Contrib Nephrol 2015; 88:152-6; discussion 157-8. [PMID: 2040177 DOI: 10.1159/000419525] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- I C Macdougall
- Institute of Nephrology, Royal Infirmary, University Hospital of Wales, Cardiff, UK
| | | | | | | | | | | |
Collapse
|
28
|
Abstract
The objective of this study was to define the risk of hearing loss among US military members in relation to their deployment experiences. Data were drawn from the Millennium Cohort Study. Self-reported data and objective military service data were used to assess exposures and outcomes. Among all 48,540 participants, 7.5% self-reported new-onset hearing loss. Self-reported hearing loss showed moderate to substantial agreement (k = 0.57-0.69) with objective audiometric measures. New-onset hearing loss was associated with combat deployment (adjusted odds ratio [AOR] = 1.63, 95% confidence interval [CI] = 1.49-1.77), as well as male sex and older age. Among deployers, new-onset hearing loss was also associated with proximity to improvised explosive devices (AOR = 2.10, 95% CI = 1.62-2.73) and with experiencing a combat-related head injury (AOR = 6.88, 95% CI = 3.77-12.54). These findings have implications for health care and disability planning, as well as for prevention programs.
Collapse
|
29
|
Damji AN, Bies K, Alibhai SMH, Jones JM. Bone health management in men undergoing ADT: examining enablers and barriers to care. Osteoporos Int 2015; 26:951-9. [PMID: 25526712 DOI: 10.1007/s00198-014-2997-6] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2014] [Accepted: 12/08/2014] [Indexed: 01/08/2023]
Abstract
UNLABELLED The study determined prostate cancer specialists' knowledge and concordance to guidelines regarding the diagnosis, management, and prevention of androgen deprivation therapy-induced osteoporosis. Despite high knowledge regarding bone health, most respondents did not routinely measure bone mineral density or use fracture risk assessment tools, suggesting a significant gap in the screening/monitoring of bone health. INTRODUCTION The purpose of this study was to determine prostate cancer specialists' knowledge, practices, self-perceived competencies and barriers to providing guideline-concordant care in the diagnosis, prevention, and management of androgen deprivation therapy (ADT)-induced osteoporosis (OP). METHODS A number of 73 Canadian radiation oncologists and 83 urologists completed questionnaires assessing (i) knowledge regarding OP and consensus guidelines for bone health management in men receiving ADT, (ii) self-assessed competencies regarding bone health management, (iii) current practices regarding OP prevention and management, and (iv) self-perceived barriers to providing guideline-concordant care. RESULTS The majority of respondents were able to correctly identify the guideline-concordant frequency of repeat dual-energy X-Ray absorptiometry (DXA) scans (76.3%), vitamin D (70.3%), and calcium (53.2%) intake and that bisphosphonates/denosumab should always be considered for patients with a history of one low-trauma fracture (57.6%). Just under 1/3 (32.5%) reported routinely measuring bone mineral density (BMD) prior to starting ADT and routinely measuring BMD 1-2 years following the initiation of ADT (36.6%). Only 4.6% of respondents routinely used a validated fracture risk assessment tool. Lowest self-assessed competency levels were reported in providing self-management education to patients to foster the uptake of healthy bone behaviors (HBBs) and managing patients who present with or develop osteopenia and OP. The most significant barriers to providing OP prevention and management were lack of time and lack of supporting structures. CONCLUSIONS Despite high knowledge about appropriate bone health care among prostate cancer specialists, there remain significant gaps in screening and monitoring of bone health, suggesting the need to develop innovative strategies to overcome barriers to implementation.
Collapse
Affiliation(s)
- A N Damji
- Undergraduate Medical Education Program, University of Toronto, Toronto, Canada
| | | | | | | |
Collapse
|
30
|
Zin RM, Ross AB, Jones JM, Dupont V. Hydrogen from ethanol reforming with aqueous fraction of pine pyrolysis oil with and without chemical looping. Bioresour Technol 2015; 176:257-266. [PMID: 25461011 DOI: 10.1016/j.biortech.2014.11.034] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/05/2014] [Revised: 11/07/2014] [Accepted: 11/08/2014] [Indexed: 06/04/2023]
Abstract
Reforming ethanol ('EtOH') into hydrogen rich syngas using the aqueous fraction from pine bio-oil ('AQ') as a combined source of steam and supplementary organic feed was tested in packed bed with Ni-catalysts 'A' (18wt%/α-Al2O3) and 'B' (25wt%/γ-Al2O3). The catalysts were initially pre-reduced by H2, but this was followed by a few cycles of chemical looping steam reforming, where the catalysts were in turn oxidised in air and auto-reduced by the EtOH/AQ mixture. At 600°C, EtOH/AQ reformed similarly to ethanol for molar steam to carbon ratios (S/C) between 2 and 5 on the H2-reduced catalysts. At S/C of 3.3, 90% of the carbon feed converted on catalyst A to CO2 (58%), CO (30%) and CH4 (2.7%), with 17wt% H2 yield based on dry organic feedstock, equivalent to 78% of the equilibrium value. Catalyst A maintained these outputs for four cycles while B underperformed due to partial reduction.
Collapse
Affiliation(s)
- R Md Zin
- Energy Research Institute, School of Chemical and Process Engineering, The University of Leeds, Leeds LS2 9JT, UK
| | - A B Ross
- Energy Research Institute, School of Chemical and Process Engineering, The University of Leeds, Leeds LS2 9JT, UK
| | - J M Jones
- Energy Research Institute, School of Chemical and Process Engineering, The University of Leeds, Leeds LS2 9JT, UK
| | - V Dupont
- Energy Research Institute, School of Chemical and Process Engineering, The University of Leeds, Leeds LS2 9JT, UK
| |
Collapse
|
31
|
Godun RM, Nisbet-Jones PBR, Jones JM, King SA, Johnson LAM, Margolis HS, Szymaniec K, Lea SN, Bongs K, Gill P. Frequency ratio of two optical clock transitions in 171Yb+ and constraints on the time variation of fundamental constants. Phys Rev Lett 2014; 113:210801. [PMID: 25479482 DOI: 10.1103/physrevlett.113.210801] [Citation(s) in RCA: 81] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2014] [Indexed: 06/04/2023]
Abstract
Singly ionized ytterbium, with ultranarrow optical clock transitions at 467 and 436 nm, is a convenient system for the realization of optical atomic clocks and tests of present-day variation of fundamental constants. We present the first direct measurement of the frequency ratio of these two clock transitions, without reference to a cesium primary standard, and using the same single ion of 171Yb+. The absolute frequencies of both transitions are also presented, each with a relative standard uncertainty of 6×10(-16). Combining our results with those from other experiments, we report a threefold improvement in the constraint on the time variation of the proton-to-electron mass ratio, μ/μ=0.2(1.1)×10(-16) yr(-1), along with an improved constraint on time variation of the fine structure constant, α/α=-0.7(2.1)×10(-17) yr(-1).
Collapse
Affiliation(s)
- R M Godun
- National Physical Laboratory, Hampton Road, Teddington TW11 0LW, United Kingdom
| | - P B R Nisbet-Jones
- National Physical Laboratory, Hampton Road, Teddington TW11 0LW, United Kingdom
| | - J M Jones
- National Physical Laboratory, Hampton Road, Teddington TW11 0LW, United Kingdom and School of Physics and Astronomy, University of Birmingham, Birmingham B15 2TT, United Kingdom
| | - S A King
- National Physical Laboratory, Hampton Road, Teddington TW11 0LW, United Kingdom
| | - L A M Johnson
- National Physical Laboratory, Hampton Road, Teddington TW11 0LW, United Kingdom
| | - H S Margolis
- National Physical Laboratory, Hampton Road, Teddington TW11 0LW, United Kingdom
| | - K Szymaniec
- National Physical Laboratory, Hampton Road, Teddington TW11 0LW, United Kingdom
| | - S N Lea
- National Physical Laboratory, Hampton Road, Teddington TW11 0LW, United Kingdom
| | - K Bongs
- School of Physics and Astronomy, University of Birmingham, Birmingham B15 2TT, United Kingdom
| | - P Gill
- National Physical Laboratory, Hampton Road, Teddington TW11 0LW, United Kingdom
| |
Collapse
|
32
|
Jackson AE, Smeltzer JP, Habermann TM, Jones JM, Burnette B, Ristow K, Wiseman GA, Macon WR, Nowakowski GS, Witzig TE. The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvement. Am J Hematol 2014; 89:865-7. [PMID: 24823914 DOI: 10.1002/ajh.23760] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2014] [Revised: 05/08/2014] [Accepted: 05/12/2014] [Indexed: 11/07/2022]
Abstract
Patients with diffuse large B-cell lymphoma (DLBCL) and pre-treatment bone marrow (BM) involvement require a restaging BM biopsy to document complete remission (CR). We investigated whether BM assessment by restaging PET-CT could obviate the need for a repeat BM biopsy. Patients with DLBCL and a positive BM biopsy at diagnosis were identified from the Mayo Clinic Lymphoma Data Base. The concordance of BM status on restaging histopathology and PET-CT reports and the positive (PPV) and negative predictive value (NPV) of PET-CT were determined. One thousand eighty patients with DLBCL were evaluated and 69 patients (6%) had DLBCL involving the BM at diagnosis. Of 46 patients who completed frontline chemoimmunotherapy, 34 had a restaging PET-CT and BM biopsy and were included in the analysis. Thirty-three patients had a negative BM by both PET-CT and BM biopsy; one patient had persistent BM involvement by biopsy and PET-CT. Thus, restaging PET-CT had 100% PPV and 100% NPV for assessing residual BM disease. The findings were validated in a prospective cohort of 68 DLBCL patients treated on a phase II clinical trial where four patients (6%) had DLBCL involving the BM at diagnosis. All had a negative BM by both restaging BM biopsy and PET-CT. Compared with the gold standard of BM biopsy, PET-CT had a 100% NPV to exclude residual BM disease after frontline therapy. If further validated, DLBCL practice guidelines and response criteria could be modified so that BM biopsy is no longer required to document CR if the restaging PET-CT is negative.
Collapse
Affiliation(s)
- Amie E. Jackson
- Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester Minnesota
| | - Jacob P. Smeltzer
- Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester Minnesota
| | - Thomas M. Habermann
- Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester Minnesota
| | - Jason M. Jones
- Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester Minnesota
| | - Brian Burnette
- Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester Minnesota
| | - Kay Ristow
- Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester Minnesota
| | | | | | - Grzegorz S. Nowakowski
- Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester Minnesota
| | - Thomas E. Witzig
- Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester Minnesota
| |
Collapse
|
33
|
Smeltzer JP, Jones JM, Ziesmer SC, Grote DM, Xiu B, Ristow KM, Yang ZZ, Nowakowski GS, Feldman AL, Cerhan JR, Novak AJ, Ansell SM. Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma. Clin Cancer Res 2014; 20:2862-72. [PMID: 24727328 DOI: 10.1158/1078-0432.ccr-13-2367] [Citation(s) in RCA: 74] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
PURPOSE Transformation of follicular lymphoma is a critical event associated with a poor prognosis. The role of the tumor microenvironment in previous transformation studies has yielded conflicting results. EXPERIMENTAL DESIGN To define cell subtypes associated with transformation, we examined tissue specimens at diagnosis from patients with follicular lymphoma that later transformed and, using immunohistochemistry (IHC), stained for CD68, CD11c, CD21, CXCL13, FOXP3, PD1, and CD14. Cell content and the pattern of expression were evaluated. Those identified as significantly associated with time to transformation (TTT) and overall survival (OS) were further characterized by flow cytometry and multicolor IHC. RESULTS Of note, 58 patients were analyzed with median TTT of 4.7 years. The pattern of PD1(+) and CD14(+) cells rather than the quantity of cells was predictive of clinical outcomes. On multivariate analysis, including the follicular lymphoma international prognostic index score, CD14(+) cells localized in the follicle were associated with a shorter TTT (HR, 3.0; P = 0.004). PD1(+) cells with diffuse staining were associated with a shorter TTT (HR, 1.9; P = 0.045) and inferior OS (HR, 2.5; P = 0.012). Multicolor IHC and flow cytometry identified CD14(+) cells as follicular dendritic cells (FDC), whereas PD1(+) cells represented two separate populations, TFH and exhausted T cells. CONCLUSION These results identify the presence of PD1(+) T cells and CD14(+) FDC as independent predictors of transformation in follicular lymphoma. Clin Cancer Res; 20(11); 2862-72. ©2014 AACR.
Collapse
MESH Headings
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor/analysis
- Biomarkers, Tumor/immunology
- Biomarkers, Tumor/metabolism
- Cell Transformation, Neoplastic/immunology
- Cell Transformation, Neoplastic/metabolism
- Cell Transformation, Neoplastic/pathology
- Dendritic Cells, Follicular/immunology
- Dendritic Cells, Follicular/metabolism
- Dendritic Cells, Follicular/pathology
- Female
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Lipopolysaccharide Receptors/immunology
- Lipopolysaccharide Receptors/metabolism
- Lymphoma, Follicular/immunology
- Lymphoma, Follicular/mortality
- Lymphoma, Follicular/pathology
- Male
- Middle Aged
- Prognosis
- Programmed Cell Death 1 Receptor/immunology
- Programmed Cell Death 1 Receptor/metabolism
- Proportional Hazards Models
- T-Lymphocytes/immunology
- T-Lymphocytes/metabolism
- T-Lymphocytes/pathology
- Tumor Microenvironment/immunology
Collapse
Affiliation(s)
- Jacob P Smeltzer
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Jason M Jones
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Steven C Ziesmer
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Deanna M Grote
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Bing Xiu
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Kay M Ristow
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Zhi Zhang Yang
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Grzegorz S Nowakowski
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Andrew L Feldman
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - James R Cerhan
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Anne J Novak
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| | - Stephen M Ansell
- Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China
| |
Collapse
|
34
|
Hossack BR, Adams MJ, Pearl CA, Wilson KW, Bull EL, Lohr K, Patla D, Pilliod DS, Jones JM, Wheeler KK, McKay SP, Corn PS. Roles of patch characteristics, drought frequency, and restoration in long-term trends of a widespread amphibian. Conserv Biol 2013; 27:1410-1420. [PMID: 24033460 DOI: 10.1111/cobi.12119] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2012] [Accepted: 04/06/2013] [Indexed: 06/02/2023]
Abstract
Despite the high profile of amphibian declines and the increasing threat of drought and fragmentation to aquatic ecosystems, few studies have examined long-term rates of change for a single species across a large geographic area. We analyzed growth in annual egg-mass counts of the Columbia spotted frog (Rana luteiventris) across the northwestern United States, an area encompassing 3 genetic clades. On the basis of data collected by multiple partners from 98 water bodies between 1991 and 2011, we used state-space and linear-regression models to measure effects of patch characteristics, frequency of summer drought, and wetland restoration on population growth. Abundance increased in the 2 clades with greatest decline history, but declined where populations are considered most secure. Population growth was negatively associated with temporary hydroperiods and landscape modification (measured by the human footprint index), but was similar in modified and natural water bodies. The effect of drought was mediated by the size of the water body: populations in large water bodies maintained positive growth despite drought, whereas drought magnified declines in small water bodies. Rapid growth in restored wetlands in areas of historical population declines provided strong evidence of successful management. Our results highlight the importance of maintaining large areas of habitat and underscore the greater vulnerability of small areas of habitat to environmental stochasticity. Similar long-term growth rates in modified and natural water bodies and rapid, positive responses to restoration suggest pond construction and other forms of management can effectively increase population growth. These tools are likely to become increasingly important to mitigate effects of increased drought expected from global climate change. Papeles de las Características del Fragmento, Frecuencia de Sequía y Restauración en las Tendencias a Largo Plazo de un Anfibio Ampliamente Distribuido.
Collapse
Affiliation(s)
- Blake R Hossack
- U.S. Geological Survey, Aldo Leopold Wilderness Institute, 790 East Beckwith Avenue, Missoula, MT, 59801, U.S.A..
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Marcelin JR, Jones JM, Costello BA. 41-year-old woman with fever, neutropenia, and elevated transaminase levels. Mayo Clin Proc 2013; 88:113-6. [PMID: 23274024 DOI: 10.1016/j.mayocp.2012.06.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2012] [Revised: 06/03/2012] [Accepted: 06/07/2012] [Indexed: 11/28/2022]
|
36
|
Fisher EM, Dupont C, Darvell LI, Commandré JM, Saddawi A, Jones JM, Grateau M, Nocquet T, Salvador S. Combustion and gasification characteristics of chars from raw and torrefied biomass. Bioresour Technol 2012; 119:157-165. [PMID: 22728196 DOI: 10.1016/j.biortech.2012.05.109] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/14/2012] [Revised: 04/26/2012] [Accepted: 05/22/2012] [Indexed: 06/01/2023]
Abstract
Torrefaction is a mild thermal pretreatment (T<300°C) that improves biomass milling and storage properties. The impact of torrefaction on the gasification and oxidation reactivity of chars from torrefied and raw biomass was investigated. Thermogravimetric analysis was used to study the differences in O(2) and steam reactivity, between chars prepared from torrefied and raw willow, under both high- and low-heating-rate conditions. High-heating-rate chars were prepared at 900°C with a residence time of 2s. Low-heating-rate chars were prepared with a heating rate of 33°C/min, a maximum temperature of 850 or 1000°C, and a residence time of 30 min or 1h, respectively, at the maximum temperature. Pretreatment by torrefaction consistently reduced char reactivity. Torrefaction's impact was greatest for high-heating-rate chars, reducing reactivity by a factor of two to three. The effect of torrefaction on a residence time requirements for char burnout and gasification was estimated.
Collapse
Affiliation(s)
- E M Fisher
- Sibley School of Mechanical and Aerospace Engineering, Upson Hall, Cornell University, Ithaca, NY 14853, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Pravetoni M, Raleigh MD, Le Naour M, Tucker AM, Harmon TM, Jones JM, Birnbaum AK, Portoghese PS, Pentel PR. Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine 2012; 30:4617-24. [PMID: 22583811 DOI: 10.1016/j.vaccine.2012.04.101] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2012] [Revised: 04/27/2012] [Accepted: 04/29/2012] [Indexed: 11/24/2022]
Abstract
Opioid conjugate vaccines have shown promise in animal models as a potential treatment for opioid addiction. Individual vaccines are quite specific and each targets only a limited number of structurally similar opioids. Since opioid users can switch or transition between opioids, we studied a bivalent immunization strategy of combining 2 vaccines that could target several of the most commonly abused opioids; heroin, oxycodone and their active metabolites. Morphine (M) and oxycodone (OXY) haptens were conjugated to keyhole limpet hemocyanin (KLH) through tetraglycine (Gly)(4) linkers at the C6 position. Immunization of rats with M-KLH alone produced high titers of antibodies directed against heroin, 6-monoacetylmorphine (6-MAM) and morphine. Immunization with OXY-KLH produced high titers of antibodies against oxycodone and oxymorphone. Immunization with the bivalent vaccine produced consistently high antibody titers against both immunogens. Bivalent vaccine antibody titers against the individual immunogens were higher than with the monovalent vaccines alone owing, at least in part, to cross-reactivity of the antibodies. Administration of a single concurrent intravenous dose of 6-MAM and oxycodone to rats immunized with the bivalent vaccine increased 6-MAM, morphine and oxycodone retention in serum and reduced the distribution of 6-MAM and oxycodone to brain. Vaccine efficacy correlated with serum antibody titers for both monovalent vaccines, alone or in combination. Efficacy of the individual vaccines was not compromised by their combined use. Consistent with the enhanced titers in the bivalent group, a trend toward enhanced pharmacokinetic efficacy with the bivalent vaccine was observed. These data support the possibility of co-administering two or more opioid vaccines concurrently to target multiple abusable opioids without compromising the immunogenicity or efficacy of the individual components.
Collapse
Affiliation(s)
- M Pravetoni
- Minneapolis Medical Research Foundation, 600 Shapiro Building, 914 8th Street, Minneapolis, MN 55404, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Ferguson CJ, Lenk GM, Jones JM, Grant AE, Winters JJ, Dowling JJ, Giger RJ, Meisler MH. Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration. Hum Mol Genet 2012; 21:3525-34. [PMID: 22581779 DOI: 10.1093/hmg/dds179] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
FIG4 is a ubiquitously expressed phosphatase that, in complex with FAB1/PIKFYVE and VAC14, regulates the biosynthesis of the signaling lipid PI(3,5)P(2). Null mutation of Fig4 in the mouse results in spongiform degeneration of brain and peripheral ganglia, defective myelination and juvenile lethality. Partial loss-of-function of human FIG4 results in a severe form of Charcot-Marie-Tooth neuropathy. Neurons from null mice contain enlarged vacuoles derived from the endosome/lysosome pathway, and astrocytes accumulate proteins involved in autophagy. Other cellular defects include astrogliosis and microgliosis. To distinguish the contributions of neurons and glia to spongiform degeneration in the Fig4 null mouse, we expressed Fig4 under the control of the neuron-specific enolase promoter and the astrocyte-specific glial fibrillary acidic protein promoter in transgenic mice. Neuronal expression of Fig4 was sufficient to rescue cellular and neurological phenotypes including spongiform degeneration, gliosis and juvenile lethality. In contrast, expression of Fig4 in astrocytes prevented accumulation of autophagy markers and microgliosis but did not prevent spongiform degeneration or lethality. To confirm the neuronal origin of spongiform degeneration, we generated a floxed allele of Fig4 and crossed it with mice expressing the Cre recombinase from the neuron-specific synapsin promoter. Mice with conditional inactivation of Fig4 in neurons developed spongiform degeneration and the full spectrum of neurological abnormalities. The data demonstrate that expression of Fig4 in neurons is necessary and sufficient to prevent spongiform degeneration. Therapy for patients with FIG4 deficiency will therefore require correction of the deficiency in neurons.
Collapse
Affiliation(s)
- C J Ferguson
- Department of Human Genetics, University of Michigan, Ann Arbor, MI 48109-6518, USA
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Jones JM, Qin R, Bardia A, Linquist B, Wolf S, Loprinzi CL. Antiemetics for chemotherapy-induced nausea and vomiting occurring despite prophylactic antiemetic therapy. J Palliat Med 2011; 14:810-4. [PMID: 21554125 DOI: 10.1089/jpm.2011.0058] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Chemotherapy-induced nausea and vomiting (CINV) is a debilitating side effect. Previous studies have primarily focused on prophylactic therapy, but no published reports have evaluated the treatment of breakthrough CINV. METHODS A prospective, pilot study was performed to provide preliminary prospective evidence of the efficacy of individual agents prescribed for the treatment of breakthrough CINV. Enrolled patients were receiving moderately or highly emetogenic chemotherapy and prophylactic treatment of CINV based on antiemetic guidelines. Patients were prescribed an antiemetic for breakthrough CINV at the discretion of their treating oncologist. If patients had breakthrough CINV that required a breakthrough antiemetic medication, they were instructed to complete a questionnaire every 30 minutes for 4 hours after taking the antiemetic. Levels of nausea (0-10), vomiting, and side effects were recorded. RESULTS Of the 96 patients enrolled, 27 (28%) reported breakthrough nausea and/or vomiting requiring medication and completed the questionniare. Eighty-eight percent (n = 24) reported the use of prochlorperazine; they experienced a 75% median nausea reduction after 4 hours, with minimal side effects. Three patients (12%) reported the use of a 5-hydroxytryptophan (5-HT) receptor antagonist for treatment of breakthrough nausea. These patients reported a median nausea reduction of 75% after 4 hours and no perceived toxicities. CONCLUSIONS Prochlorperazine and 5-HT receptor antagonists appear to be effective breakthrough antiemetic therapies. The described study methodology can be used to conduct randomized clinical trials to find more effective drugs for treating established nausea.
Collapse
Affiliation(s)
- Jason M Jones
- Department of Health Sciences Research, Mayo Clinic , Rochester, MN 55905, USA
| | | | | | | | | | | |
Collapse
|
40
|
|
41
|
Abstract
A survey was undertaken to ascertain the extent to which women veterinarians in New Zealand were employing their veterinary skills, and to identify some of the factors which affect women;s ability or choice to work full-time in their profession. Replies were received from 115 of 140 women registered by the New Zealand Veterinary Surgeons Board. Women in full-time veterinary employment at the time of the survey made up 63% of the sample, 19% were employed part-time, and 18% were not working. Women with children on average had worked as veterinary surgeons proportionately less time since qualification than either single women or women with no children. Women with children worked in their profession for a significantly greater proportion of time if they had both emotional and physical support in the home. Women who employed paid household help were in a minority in the sample. The distribution of women in different fields of veterinary employment was similar to that of a similar sized sample of men. The main reasons women gave for reducing their work level were pregnancy and lactation, difficulties in combining professional work with family commitments, a desire to spend time with children at home, and difficulty in finding a suitable position.
Collapse
Affiliation(s)
- J M Jones
- Department of Veterinary Pathology and Public Health, Massey University, Palmerston North
| |
Collapse
|
42
|
Abstract
A study of 40 Hereford cattle dwarfs in New Zealand confirmed that dwarfism in this country was morphologically the same as that described in North American Herefords and that its mode of inheritance was as an autosomal recessive trait. The histological architecture of growth plates was essentially normal but palisading columns were shorter and more irregular than in controls. A small proportion of chondrocytes in dwarf cartilage showed increased areas of cytoplasmic metachromasia, which probably coincided with increased cystic dilations of endoplasmic reticulum containing granular material as noted by electronmicroscopy. The above growth-plate abnormalities were neither prominent nor consistent enough to be of diagnostic significance; nor do they currently help understanding of the underlying pathogenic mechanism of dwarfing. Histological and mucopolysaccharide excretion studies unequivocally demonstrated that this disease is not a mucopolysaccharidosis as had previously been reported.
Collapse
Affiliation(s)
- J M Jones
- Department of Veterinary Pathology & Public Health, Massey University, Palmerston North
| | | |
Collapse
|
43
|
Abstract
An eight-month-old female crossbred terrier was presented with a short history of diarrhoea, dyspnoea and abdominal distension. Clinical examination revealed thoracic effusion, ascites, and subcutaneous oedema. Hypoalbuminaemia, hypoglobulinaemia and lymphopaenia were all present. Histological examination of a jejunal biopsy confirmed a diagnosis of intestinal Iymphangiectasia. Full clinical recovery followed treatment by dietary management.
Collapse
Affiliation(s)
- B R Jones
- Department of Veterinary Clinical Sciences, Massey University
| | | | | | | | | |
Collapse
|
44
|
Adams JMM, Ross AB, Anastasakis K, Hodgson EM, Gallagher JA, Jones JM, Donnison IS. Seasonal variation in the chemical composition of the bioenergy feedstock Laminaria digitata for thermochemical conversion. Bioresour Technol 2011; 102:226-34. [PMID: 20685112 DOI: 10.1016/j.biortech.2010.06.152] [Citation(s) in RCA: 79] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2010] [Revised: 06/17/2010] [Accepted: 06/25/2010] [Indexed: 05/25/2023]
Abstract
To avoid negative impacts on food production, novel non-food biofuel feedstocks need to be identified and utilised. One option is to utilise marine biomass, notably fast-growing, large marine 'plants' such as the macroalgal kelps. This paper reports on the changing composition of Laminaria digitata throughout it growth cycle as determined by new technologies. The potential of Laminaria sp. as a feedstock for biofuel production and future biorefining possibilities was assessed through proximate and ultimate analysis, initial pyrolysis rates using thermo-gravimetric analysis (TGA), metals content and pyrolysis gas chromatography-mass spectrometry. Samples harvested in March contained the lowest proportion of carbohydrate and the highest ash and alkali metal content, whereas samples harvested in July contained the highest proportions of carbohydrate, lowest alkali metals and ash content. July was therefore considered the most suitable month for harvesting kelp biomass for thermochemical conversion to biofuels.
Collapse
Affiliation(s)
- J M M Adams
- Bioenergy and Biorenewables, Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Gogerddan, Aberystwyth SY23 3EB, United Kingdom
| | | | | | | | | | | | | |
Collapse
|
45
|
Pachman DR, Jones JM, Loprinzi CL. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions. Int J Womens Health 2010; 2:123-35. [PMID: 21072305 PMCID: PMC2971731 DOI: 10.2147/ijwh.s7721] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2010] [Indexed: 12/21/2022] Open
Abstract
Hot flashes are one of the most common and distressing symptoms associated with menopause, occurring in more than 75% of postmenopausal women. They are especially problematic in breast cancer patients since some breast cancer therapies can induce hot flashes. For mild hot flashes, it is proposed that behavioral modifications are the first step in management. Hormonal therapies, including estrogens and progestogens, are the most well known effective agents in relieving hot flashes; however, the safety of these agents is controversial. There is an increasing amount of literature on nonhormonal agents for the treatment of hot flashes. The most promising data regard newer antidepressant agents such as venlafaxine, which reduces hot flashes by about 60%. Gabapentin is another nonhormonal agent that is effective in reducing hot flashes. While many complimentary therapies, including phytoestrogens, black cohosh, and dehydroepiandrosterone, have been explored for the treatment of hot flashes; none can be recommended at this time. Furthermore, there is a lack of strong evidence to support exercise, yoga, or relaxation for the treatment of hot flashes. Paced respirations and hypnosis appear to be promising enough to warrant further investigation. Another promising nonpharmacological therapy, currently under investigation, involves a stellate ganglion block.
Collapse
|
46
|
Abstract
Group A streptococcal cell wall fragments inhibited phagocytosis of unrelated particles by rabbit polymorphonuclear leukocytes and inhibited the growth of rabbit kidney cells in vitro. Activity was associated with the mucopeptide moiety. Whole streptococci or the cytoplasmic fraction were less effective than cell wall fragments. The cell wall fragments of group D streptococci, Bacillus megaterium, and Escherichia coli were inactive. The inhibition of phagocytosis illustrates one way in which microbial components may influence the immune response. The toxicity for tissue cultures of rabbit kidney cell monolayers was greatest during the phase of active cell division. This appears to be a direct toxic effect of cell wall fragments on mammalian cells and may be related to the in vivo injury previously reported for streptococcal cell walls.
Collapse
Affiliation(s)
- J M Jones
- Department of Bacteriology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514
| | | |
Collapse
|
47
|
Affiliation(s)
- J M Jones
- Dunton Hall Veterinary Clinic, Kingsbury Road, Curdworth, Sutton Coldfield, West Midlands, UK.
| |
Collapse
|
48
|
Waite JG, Jones JM, Turek EJ, Dunne CP, Wright AO, Yang TCS, Beckwitt R, Yousef AE. Production of shelf-stable ranch dressing using high-pressure processing. J Food Sci 2009; 74:M83-93. [PMID: 19323763 DOI: 10.1111/j.1750-3841.2008.01064.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
High-pressure processing (HPP) can reduce or eliminate microorganisms of concern in food without deteriorating product quality; however, quality benefits must justify the substantial capital investment for the utilization of this technology. HPP is particularly a beneficial preservation technology for products damaged by thermal treatments or when product quality could be improved by reformulation to raise pH or eliminate chemical preservatives. The primary objectives of this study were to determine the efficacy of HPP to protect premium ranch dressing (pH 4.4) from microbial spoilage and to assess changes in physical, chemical, and sensory attributes throughout the product's shelf life. In inoculated-packages studies, the efficacy of HPP was measured against ranch dressing spoilage organisms: Pediococcus acidilactici, Lactobacillus brevis, and Torulaspora delbrueckii. HPP treatment (600 MPa, 3 min) decreased population of P. acidilactici, the most pressure-resistant spoilage organism tested, by >or= 6.4 log CFU/g. During a shelf-life study of edible product, treating ranch dressing at 600 MPa for 5 min effectively prevented microbial spoilage throughout the storage period (26 wk at 4 and 26 degrees C). The pH and emulsion stability of ranch dressing were not adversely influenced by HPP. Extended storage of HPP product for 16 to 26 wk at 26 degrees C resulted in a decrease in consumer acceptance and significant changes in color and organic acid profile (specifically, increased pyroglutamic acid). These changes were consistent with those expected during extended storage of commercially available products. HPP may be used to produce premium ranch dressing, with defined shelf-life and storage conditions, without significantly changing product attributes.
Collapse
Affiliation(s)
- J G Waite
- Dept of Food Science and Technology, Parker Food Science Building, The Ohio State Univ, Columbus, OH 43210, USA
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Jones OY, Lacson A, Zeng X, Jones JM, Katti K, Cahill RA, Ahmed AA. Long-term follow-up after non-myeloablative transplant of bone and marrow in BXSB mice. Lupus 2009; 18:813-21. [DOI: 10.1177/0961203309104391] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
We present long-term outcomes of BXSB mice after non-myeloablative bone marrow transplants using major histocompatability complex (MHC)-matched cells. Groups differed in sources of donor lymphocytes or mesenchymal stromal cells (MSC). Unfractionated marrow cells from green fluorescent protein (GFP) transgenic (Tg) mice (BMT group) or from RAG1−/− B6 mice (RAG group) were injected intravenously (i.v.) into irradiated (550 cGy) hosts. As a source of mesenchymal cells, bone chips from GFP-Tg were injected intraperitoneally alone (MSC group) or along with i.v. bone marrow cells (BMT + MSC group). Controls were untreated mice (UnTx) or mice exposed to radiation only (Rad Cont). At 62 weeks post-transplant, surviving mice were harvested for histopathology, flow cytometry and real time polymerase chain reaction (RT-PCR). The mice from BMT + MSC group had the best outcomes for survival rates (71.4% vs. 43.8%), renal scores (2.9% vs. 28.8% glomerular sclerosis) and percent splenic monocytes (4.2 vs. 11.3%) compared with mice from Rad Cont. Improvement in RAG and BMT groups was less prominent but were comparable with one another. Although MSC alone were not sufficient to control the renal pathology, it limited the expansion of CD4−CD8− T cell populations without a change in Foxp3 expression. The results suggest the importance of the innate immune system in disease pathogenesis and a role for MSC in immunomodulation.
Collapse
Affiliation(s)
- OY Jones
- Department of Pediatrics, Walter Reed Army Medical Center, Georgia Avenue, NW, Washington DC, USA
| | - A Lacson
- Department of Laboratory Medicine and Pathology, University of Alberta Hospital, Mackenzie Health Sciences Centre. Edmonton, Alberta, Canada
| | - X Zeng
- R&D, SABiosciences Corporation, Executive Way, Frederick, MD, USA
| | - JM Jones
- Immunology Consultant, Potomac, MD, USA
| | - K Katti
- George Washington University School of Medicine, Washington, DC, USA
| | - RA Cahill
- Cardinal Glennon Hospital, South Grand Avenue, St. Louis, MO, USA
| | - AA Ahmed
- Department of Pathology and Laboratory Medicine, Children's Mercy Hospitals and Clinics, Gillham Road, Kansas City, MO, USA
| |
Collapse
|
50
|
Whiteman SC, Yang Y, Jones JM, Spiteri MA. FTIR spectroscopic analysis of sputum: preliminary findings on a potential novel diagnostic marker for COPD. Ther Adv Respir Dis 2009; 2:23-31. [PMID: 19124356 DOI: 10.1177/1753465807087972] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
COPD is a common, progressively disabling disease and a major health burden worldwide. Fourier transform infrared (FTIR) spectroscopy provides for sensitive analysis of complex biological samples. COPD pathogenesis involves quantitative and qualitative changes in sputum biosynthesis. This first study explores whether FTIR can produce distinct spectral profiles of human sputum, and capture differences between COPD and health. Sputum obtained from 15 COPD patients and 15 healthy volunteers was analysed using FTIR spectroscopy; differences in peak positions, height and configuration were identified and measured. All samples gave reproducible characteristic IR absorption spectra. The most relevant regions identified were the amide and glycogen rich regions, showing crucial spectral differences between health and COPD relating to peak position shifts or intensity alteration. These novel preliminary findings support further exploration of FTIR sputum profiling in a clinical study to determine its potential as a practical method for monitoring COPD.
Collapse
Affiliation(s)
- S C Whiteman
- Lung Research Group, Institute of Science and Technology in Medicine, University Hospital of North Staffordshire / Keele University, Staffordshire, UK
| | | | | | | |
Collapse
|